var data={"specialtyName":"Authors and Editors in Allergy and

Immunology","contributorTypes":[{"name":"Editors-in-Chief","contributors":
[{"name":"Bruce S Bochner, MD","credentials":["Editor-in-Chief — Allergy and
Immunology\n","Section Editor — Adult Allergy; Asthma\n","Samuel M Feinberg
Professor of Medicine \n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIAID; NHLBI,
Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma, COPD, anaphylaxis, imaging,
eosinophilic granulomatosis with polyangiitis, food allergy, Bruton's tyrosine
kinase, mastocytosis]. Consultant/Advisory Boards: GSK; AstraZeneca; TEVA;
Genentech; Allakos [Eosinophil and mast cell-related disease (Mepolizumab,
reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand; anti-Siglec-8
antibodies [Eosinophil and mast cell-associated disease (AK002 [in clinical trials;
not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos [Eosinophil and
mast cell-associated diseases (AK002 [in clinical trials; not yet FDA-approved])].
Other Financial Interest: Elsevier [Publication royalties (Allergy and
Immunology)]."},{"name":"E Richard Stiehm, MD","credentials":["Editor-in-Chief —
Allergy and Immunology\n","Section Editor — Immunology and
Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David
Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA
Biologics [Infections of respiratory syncytial virus in organ transplants
(Respiratory syncytial virus immune globulin)]."},{"name":"Robert A Wood,
MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor —
Pediatric Allergy\n","Professor of Pediatrics\n","Johns Hopkins University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV
Technologies; Aimmune; Astellas; HAL-Allergy [Food allergy]."}]},{"name":"Deputy
Editors","contributors":[{"name":"Anna M Feldweg, MD","credentials":["Director,
Editorial Management — UpToDate\n","Deputy Editor — Allergy and
Immunology\n","Assistant Professor of Medicine, Part-time\n","Harvard Medical
School"],"disclosure":""},{"name":"Elizabeth TePas, MD, MS","credentials":["Senior
Deputy Editor — UpToDate\n","Deputy Editor — Allergy and Immunology\n","Deputy
Editor — Pediatrics\n","Instructor in Medicine\n","Harvard Medical
School"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"N
Franklin Adkinson, Jr, MD","credentials":["Section Editor — Drug
Allergy\n","Professor of Medicine\n","Johns Hopkins University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: ViiV Healthcare; Amgen; Merck;
Boehringer Ingelheim [Hypersensitivity reactions and anaphylaxis in drugs under
development (Fluoroquinolones)]; Pfizer; Alexion; aTyr Pharma; Genzyme/Sanofi;
Synageva [DSMB for drug products under development]; Merck [Allergen immunotherapy
products (Oral tablets for allergen immunotherapy)]; DBV Technologies [Epicutaneous
immunotherapy products]. Equity Ownership/Stock Options: AllerQuest [Penicillin
allergy diagnosis (Penicilloyl polylysine)]; DBV Technologies [Epicutaneous
immunotherapy (Viaskin patches)]."},{"name":"Bruce S Bochner, MD","credentials":
["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Adult Allergy;
Asthma\n","Samuel M Feinberg Professor of Medicine \n","Northwestern University
Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
NIAID; NHLBI, Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma, COPD,
anaphylaxis, imaging, eosinophilic granulomatosis with polyangiitis, food allergy,
Bruton's tyrosine kinase, mastocytosis]. Consultant/Advisory Boards: GSK;
AstraZeneca; TEVA; Genentech; Allakos [Eosinophil and mast cell-related disease
(Mepolizumab, reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand;
anti-Siglec-8 antibodies [Eosinophil and mast cell-associated disease (AK002 [in
clinical trials; not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos
[Eosinophil and mast cell-associated diseases (AK002 [in clinical trials; not yet
FDA-approved])]. Other Financial Interest: Elsevier [Publication royalties (Allergy
and Immunology)]."},{"name":"Francisco A Bonilla, MD, PhD","credentials":["Section
Editor — Immunology and Immunodeficiency\n","Associate Professor of
Pediatrics\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Charles River Associates International (Germany) GmbH [Consultant(Genetics of
immunodeficiency)]; Grand Rounds Health [Consultant(Patient care)]; Green Cross,
Parexel [DSM(Immunoglobulin therapy)]; Guidepoint Global Advisors
[Consultant(General immunodeficiency)]; Health Resources Services
Administration/HHS [Consultant(Vaccine injury)]; Immune Deficiency Foundation
[Consultant(Patient care / Advisory board)]; Louis August Jonas Foundation [Board
Member]; Sarepta [Consultant(Biologic therapy)]."},{"name":"Jonathan Corren,
MD","credentials":["Section Editor — Rhinitis and Sinusitis\n","Associate Clinical
Professor of Medicine\n","David Geffen School of Medicine at
UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Stallergenes Greer
[Sublingual immunotherapy trial]; Regeneron Pharmaceuticals [Pilot study of grass
nasal allergen challenge]."},{"name":"Peter S Creticos, MD","credentials":["Section
Editor — Immunotherapy\n","Associate Professor of Medicine\n","Johns Hopkins
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Stallergenes-Greer [Immunotherapy (SLIT)]; Circassia [Immunotherapy
(Peptides)]. Consultant/Advisory Boards: Circassia; Greer; ITI [Immunotherapy
(SCIT; SLIT)]; Allakos [Cytokine antagonists]; ASIT [AIT]."},{"name":"Helen V
Firth, DM, FRCP, DCH","credentials":["Section Editor — Genetics\n","Consultant
Clinical Geneticist\n","Addenbrooke's Hospital, Cambridge, UK"],"disclosure":""},
{"name":"David B Golden, MD","credentials":["Section Editor — Bites and
Stings\n","Associate Professor of Medicine\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Asthma
(Omalizumab)]. Speaker's Bureau: Genentech [Asthma (Omalizumab)];
Stallergenes/Greer [Allergic rhinitis (Sweet vernal, orchard, perennial rye,
Timothy, and Kentucky blue grass mixed pollens allergen extract)]."},
{"name":"Sihoun Hahn, MD, PhD","credentials":["Section Editor —
Genetics\n","Professor of Pediatrics\n","University of Washington School of
Medicine, Seattle Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial
Support: Genzyme [Pompe disease, registry study (Alglucosidase alpha)]; Alexion
[Hypophosphatasia (Asfotase alpha)]; Shire [Hunter disease (Idursulfase)]; BioMarin
[Registry study]; Shire [Registry study]; Wilson Therapeutics AB [Wilson disease
(WTX 101-203-301 study)]; Genzyme [Pompe disease, ADVANCE (Alglucosidase alfa)]."},
{"name":"John M Kelso, MD","credentials":["Section Editor –
Anaphylaxis\n","Division of Allergy, Asthma, and Immunology\n","Scripps Clinic, San
Diego, CA"],"disclosure":""},{"name":"Marisa Klein-Gitelman, MD,
MPH","credentials":["Section Editor — Pediatric Rheumatology\n","Chief, Division of
Rheumatology\n","Ann & Robert H. Lurie Children's Hospital of Chicago\n","Professor
of Pediatrics\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Luigi D Notarangelo, MD","credentials":
["Section Editor — Immunology and Immunodeficiency\n","Bethesda,
MD"],"disclosure":""},{"name":"Jordan S Orange, MD, PhD","credentials":["Section
Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","Chief of
Immunology, Allergy, and Rheumatology\n","Baylor College of Medicine\n","Texas
Children's Hospital"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics;
Shire; CSL Behring; Grifols [Primary immunodeficiency (IVIG, SCIG)]."},
{"name":"Jennifer M Puck, MD","credentials":["Section Editor — Immunology and
Immunodeficiency\n","Professor of Pediatrics\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards (spouse): Pfizer [Rare
diseases]. Employment (spouse): Invitae [Gene sequencing]. Equity Ownership/Stock
Options (spouse): Invitae [Gene sequencing]."},{"name":"Sarbjit Saini,
MD","credentials":["Section Editor — Urticaria and Angioedema\n","Associate
Professor of Medicine\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma,
urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)].
Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune
[Urticaria (Omalizumab)]."},{"name":"Scott H Sicherer, MD, FAAAAI","credentials":
["Section Editor — Food Allergy\n","Professor of Pediatrics\n","Icahn School of
Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: HAL
Allergy [Food allergy]; Food Allergy Research and Education [Food allergy]; NIAID
[Food allergy clinical trials]. Consultant/Advisory Boards: International
Association for FPIES [FPIES]."},{"name":"E Richard Stiehm, MD","credentials":
["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Immunology and
Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David
Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA
Biologics [Infections of respiratory syncytial virus in organ transplants
(Respiratory syncytial virus immune globulin)]."},{"name":"Robert Sundel,
MD","credentials":["Section Editor — Pediatric Rheumatology\n","Associate Professor
of Pediatrics\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Pfizer [Juvenile idiopathic arthritis (Tofacitinib)]. Other
Financial Interest: Expert consultant in patent case involving application for
biosimilar status of an anti-TNF agent."},{"name":"Robert A Wood,
MD","credentials":["Editor-in-Chief — Allergy
and Immunology\n","Section Editor — Pediatric Allergy\n","Professor of
Pediatrics\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies;
Aimmune; Astellas; HAL-Allergy [Food allergy]."}]},{"name":"Editorial
Assistants","contributors":[{"name":"Aisling D Francoeur, BA","credentials":
["Senior Development Editor — UpToDate"],"disclosure":""},{"name":"Elizabeth
Packer, MA","credentials":["Development Editor — UpToDate"],"disclosure":""}]},
{"name":"Authors","contributors":[{"name":"Judith A Aberg, MD","credentials":
["Chief, Division of Infectious Diseases\n","George Baehr Professor of
Medicine\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [HIV
investigational study on attachment inhibitor (GSK 663068)]; Gilead [HIV (Tenofovir
alenfenamide)]; GSK [Long acting injectables (Cabotegravir, rilpivirine)].
Consultant/Advisory Boards: Gilead [HIV (TDF)]; Janssen [HIV (Darunavir)]; Merck
[HIV (Raltegravir)]; Viiv [HIV [ABC, 3TC, DTG)]."},{"name":"Loutfi Sami Aboussouan,
MD","credentials":["Staff\n","Cleveland Clinic Foundation"],"disclosure":""},
{"name":"Clara Abraham, MD","credentials":["Associate Professor of
Medicine\n","Yale University"],"disclosure":""},{"name":"Vikki M Abrahams,
PhD","credentials":["Associate Professor \n","Yale University School of
Medicine"],"disclosure":""},{"name":"Elaine J Abrams, MD","credentials":["Professor
of Pediatrics and Epidemiology\n","Columbia
University"],"disclosure":"Consultant/Advisory Boards: Viiv [Pediatric
antiretroviral medications (Dolutegravir, maraviroc)]."},{"name":"Seema S Aceves,
MD, PhD","credentials":["Associate Professor of Pediatrics and
Medicine\n","University of California, San Diego\n","Rady Children's Hospital, San
Diiego"],"disclosure":"Grant/Research/Clinical Trial Support: Ferring Research
Institute [Eosinophilic esophagitis]. Consultant/Advisory Boards: Regeneron Pharma
[Eosinophilic esophagitis (Dupilumab)]. Patent Holder: UCSD [Oral viscous
budesonide licensed by Shire]."},{"name":"Ian M Adcock, FSB","credentials":
["Professor of Cell & Molecular Biology, Airways Disease Section\n","National Heart
and Lung Institute, Imperial College London"],"disclosure":"Speaker’s Bureau:
AstraZeneca [Corticosteroid insensitivity in severe asthma]. Consultant/Advisory
Boards: Vectura [Anti-IL-5]; AstraZeneca [Anti-IL-5R (Benralizumab)]."},
{"name":"Nezam H Afdhal, MD, FRCPI","credentials":["Senior Physician in
Hepatology\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; BMS; Gilead
[HCV Studies]. Consultant/Advisory Boards: AbbVie; Echosens; Gilead Sciences;
GlaxoSmithKline; Jannsen Pharmaceutica; Ligand; Merck & Co; Novartis International
AG; Spring Bank Pharmaceuticals; TRIO HealthCare [Liver Disease]. Equity
Ownership/Stock Options: Spring Bank Pharmaceuticals [HBV, RSV]. Employment: Spring
Bank Pharmaceuticals [HBV, RSV] - No relevant conflict on topic."},{"name":"Asghar
Aghamohammadi, MD, PhD","credentials":["Professor of Pediatrics\n","Tehran
University of Medical Sciences"],"disclosure":""},{"name":"Sam Ahn,
MD","credentials":["Assistant Clinical Professor of
Medicine/Pediatrics\n","University of Arizona School of
Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":["Clinical
Associate Professor of Medicine\n","University of California, San
Francisco"],"disclosure":""},{"name":"Mübeccel Akdis, MD, PhD","credentials":["Head
of Immunodermatology\n","Swiss Institute of Allergy and Asthma Research
(SIAF)"],"disclosure":""},{"name":"Cem Akin, MD, PhD","credentials":["Professor of
Medicine \n","University of Michigan"],"disclosure":"Consultant/Advisory Boards:
Deciphera [Mastocytosis]; Patara Pharma [Mastocytosis (Cromolyn)]; Novartis
[Mastocytosis (Midostaurin)]. Patent Holder: LAD2 cell line [Mast cells]."},
{"name":"Praveen Akuthota, MD","credentials":["Associate Clinical
Professor\n","University of California, San
Diego"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Severe asthma,
eosinophil biology]. Consultant/Advisory Boards: GlaxoSmithKline [EGPA
(Mepolizumab)]; AstraZenca [Asthma (Benralizumab)]; Ambrx [Breast cancer]."},
{"name":"Doerthe A Andreae, MD","credentials":["Assistant Professor\n","Penn State
Medical Center"],"disclosure":""},{"name":"Rajesh Aneja, MD, FAAP","credentials":
["Associate Professor \n","Department of Critical Care Medicine\n","University of
Pittsburgh School of Medicine"],"disclosure":""},{"name":"Gerald B Appel,
MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of
Medicine\n","Columbia University College of Physicians and
Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus
Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal
Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-
0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta
[Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis
(Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx
[Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau:
Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)].
Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers
Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi;
Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives
(Drugs under development for immunosuppression)]."},{"name":"Andrea J Apter, MD,
MSc, MA","credentials":["Professor of Medicine\n","Section of Allergy & Immunology,
Division of Pulmonary, Allergy, Critical Care Medicine\n","Perelman School of
Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Steven M Archer,
MD","credentials":["Professor\n","University of Michigan, Department of
Ophthalmology and Visual Sciences"],"disclosure":""},{"name":"Riccardo Asero,
MD","credentials":["Head Ambulatorio di Allergologia\n","Clinica San Carlo, Paderno
Dugnano (MI), Italy"],"disclosure":""},{"name":"Jon C Aster, MD","credentials":
["Professor of Pathology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic
malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch
inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis
[Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options:
Cellestia; Anastasis."},{"name":"John P Atkinson, MD","credentials":["Samuel B
Grant Professor of Medicine\n","Professor of Molecular Microbiology\n","Chief,
Division Rheumatology\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Antoine Azar, MD","credentials":["Assistant
Professor of Medicine\n","Division of Allergy and Clinical Immunology\n","Johns
Hopkins University School of Medicine"],"disclosure":""},{"name":"John W Baddley,
MD, MSPH","credentials":["Professor of Medicine\n","Birmingham VA Medical
Center\n","University of Alabama at Birmingham"],"disclosure":"Consultant/Advisory
Boards: Merck [Fungal/transplant]. Other Financial Interest: Pfizer [Rheumatoid
arthritis (tofacitinib)]; R-Pharma [Rheumatoid arthritis (olofizumab)]."},
{"name":"Ronald C Balkissoon, MD","credentials":["Associate Professor of
Medicine\n","University of Colorado Health Sciences
Center"],"disclosure":"Speaker’s Bureau: Astra Zeneca [COPD
(Budesonide/formoterol)]; Sunovion [COPD (Arformoterol tartrate,
indacaterol/glycopyrolate)]; Genentech [Asthma (Omalizumab)]. Consultant/Advisory
Boards: Astra Zeneca [COPD (Budesonide/formoterol)]; Sunovion [COPD (Arformoterol
tartrate, indacaterol/glycopyrolate)]; Genentech [Asthma (Omalizumab)]."},
{"name":"Zuhair K Ballas, MD","credentials":["Professor of Medicine\n","University
of Iowa"],"disclosure":"Consultant/Advisory Boards: Immune Deficiency Foundation
[Counseling for immunodeficiency patients and clinicians]; Checkmate Pharma [CpG in
tumor immunotherapy (Products in trial)]."},{"name":"Mark Ballow,
MD","credentials":["Professor of Pediatrics\n","All Children’s
Hospital\n","University of South Florida School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring
[Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau:
Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency
(Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire
[Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety
Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},
{"name":"Aleena Banerji, MD","credentials":["Associate Professor\n","Training
Program Director\n","Massachusetts General
Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Hereditary
angioedema (Icatibant)]; CSL [Hereditary angioedema (Cinryze, Berinert)].
Consultant/Advisory Boards: Shire [Hereditary angioedema (Icatibant)]; Alnylam
[Hereditary angioedema]; CSL [Hereditary angioedema (Berinert)]; Biocryst
[Hereditary angioedema (No product FDA approved yet)]."},{"name":"Kathleen C
Barnes, PhD","credentials":["Director, Biomedical Informatics and Personalized
Medicine Center and Division\n","University of Colorado School of
Medicine"],"disclosure":""},{"name":"Peter J Barnes, DM, DSc, FRCP,
FRS","credentials":["Editor-in-Chief — Pulmonary and Critical Care
Medicine\n","Section Editor — Asthma\n","Professor of Medicine\n","National Heart
and Lung Institute, Imperial College,
London"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma,
COPD (Symbicort)]; GSK [Asthma, COPD (Advair, fluticasone furoate, vilanterol)];
Novartis [COPD (Indacaterol)]; Boehringer [COPD (Tiotropium, olodaterol)]; Chiesi
[Asthma, COPD (Foster)]; Pfizer [COPD]; Takeda [COPD (Roflumilast)];. Speaker's
Bureau: AstraZeneca [Asthma (Symbicort)]; Pfizer [COPD (Tiotropium)]; Novartis
[COPD (Indacaterol, glucopyrolate, Ultibro)]; Boehringer [COPD (Tiotropium,
olodaterol)]; Chiesi [Asthma (Foster)]. Consultant/Advisory Board: AstraZeneca
[Asthma]; GSK [Asthma]; Pfizer [COPD]; Novartis [COPD]; Boehringer [COPD]; Chiesi
[COPD]; Teva [COPD]; Glenmark [COPD]; Zambon [Asthma]."},{"name":"John G Bartlett,
MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — HIV;
Pulmonary Infections\n","Professor Emeritus\n","Johns Hopkins University School of
Medicine"],"disclosure":""},{"name":"Michael Barza, MD","credentials":["Professor
of Medicine\n","Tufts University School of Medicine"],"disclosure":""},
{"name":"Maria G Belvisi, PhD","credentials":["Professor of Respiratory
Pharmacology\n","National Heart & Lung Institute, Imperial College
London"],"disclosure":""},{"name":"Nancy Berliner, MD","credentials":["Professor of
Medicine\n","Harvard Medical School\n","H. Franklin Bunn Professor of Hematology
and Chief, Division of Hematology \n","Brigham and Women's
Hospital"],"disclosure":""},{"name":"Bonnie L Bermas, MD","credentials":["Professor
of Medicine\n","UT Southwestern Medical Center"],"disclosure":""},{"name":"David I
Bernstein, MD","credentials":["Professor of Clinical Medicine and Environmental
Health\n","University of Cincinnati College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Glaxo, TEVA, Astra
Zeneca, Pearl, Novartis, Genentech, Circassia, Pfizer, Mylan, Boeringer Ingelheim,
Amgen, Array [Clinical trials of asthma therapies, new COPD drugs, new forms of
immunotherapy, biologics for treatment of asthma or hives]. Speaker's Bureau:
Merck, Astra Zeneca(Asthma management). Consultant/Advisory Boards: TEVA, Merck,
Glaxo [Anti-IL5 for asthma, sublingual immunotherapy]."},{"name":"Jonathan A
Bernstein, MD","credentials":["Professor of Medicine\n","University of Cincinnati
College of Medicine"],"disclosure":""},{"name":"Leonard Bielory, MD","credentials":
["Professor of Medicine\n","Thomas Jefferson University Kimmel School of
Medicine\n","Professor of Medicine\n","Rutgers University"],"disclosure":""},
{"name":"Jack JH Bleesing, MD, PhD","credentials":["Professor of
Pediatrics\n","Cincinnati Children's Hospital Medical Center"],"disclosure":""},
{"name":"Kimberly G Blumenthal, MD, MSc","credentials":["Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"S Allan Bock,
MD","credentials":["Research Affiliate, Department of Pediatrics\n","National
Jewish Health\n","Clinical Professor, Department of Pediatrics\n","Children's
Hospital Colorado"],"disclosure":""},{"name":"Francisco A Bonilla, MD,
PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Associate
Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Charles River Associates
International (Germany) GmbH [Consultant(Genetics of immunodeficiency)]; Grand
Rounds Health [Consultant(Patient care)]; Green Cross, Parexel [DSM(Immunoglobulin
therapy)]; Guidepoint Global Advisors [Consultant(General immunodeficiency)];
Health Resources Services Administration/HHS [Consultant(Vaccine injury)]; Immune
Deficiency Foundation [Consultant(Patient care / Advisory board)]; Louis August
Jonas Foundation [Board Member]; Sarepta [Consultant(Biologic therapy)]."},
{"name":"Peter A L Bonis, MD","credentials":["Chief Medical Officer of Clinical
Effectiveness (UpToDate, Clinical Drug Information, and Emmi Solutions)\n","Deputy
Editor — Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts
University School of Medicine"],"disclosure":""},{"name":"Louis-Philippe Boulet,
MD","credentials":["Professor of Medicine\n","Laval
University"],"disclosure":"Grant/Research/Clinical Trial Support: Non profit
grants-Asmacure [Asthma (ASM-024)], AstraZeneca [Asthma (Benralizumab)],
GlaxoSmithKline[Asthma (NA)], Novartis[Asthma (Xolair)], Ono Pharma\r\n[Asthma
(ONO-6950)], Sanofi [Asthma (Dupilumab)]. Speaker’s Bureau: Lecture fees from
AstraZeneca [Asthma (Benralizumab)], Novartis [Asthma (Xolair)], Methapharm [Asthma
(N/A)]. Consultant/Advisory Boards: AstraZeneca [Asthma (Benralizumab)], Novartis
[Asthma (Xolair)]."},{"name":"Lee H Bouwman, MD, PhD, FEBVS","credentials":
["Vascular Surgeon\n","Atrium Medical Center, Heerlen, The
Netherlands"],"disclosure":""},{"name":"Melinda J Braskett, MD","credentials":
["Assistant Professor, Clinical Pediatrics\n","Division of Clinical Immunology and
Allergy\n","Children's Hospital Los Angeles\n","Keck School of Medicine at
University of Southern California"],"disclosure":""},{"name":"Nancy L Breisch,
PhD","credentials":["Senior Research Associate\n","University of
Maryland"],"disclosure":""},{"name":"Heimo Breiteneder, PhD","credentials":
["Professor of Medical Biotechnology\n","Medical University of Vienna, Vienna,
Austria"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":["Assistant
Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},
{"name":"Kees Brinkman, MD, PhD","credentials":["Department of Internal
Medicine\n","Onze Lieve Vrouwe Gasthuis, Amsterdam, The
Netherlands"],"disclosure":"Consultant/Advisory Boards: BMS [cART (didanosine,
stavudine, atazanavir)]; Viiv [cART (zidovudine, abacavir, lamivudine,
dolutegravir)]; Gilead [cART (tenofovir, emtricitabine, elvitegravir)]; Jansen
[cART (rilpiverin, darunavir)]; MSD [cART (raltegravir)]."},{"name":"Maarten W
Bronkhorst, MD, PhD, FEBS, FRCS","credentials":["Attending Trauma
Surgeon\n","Haaglanden Medical Center"],"disclosure":""},{"name":"Kathleen M
Buchheit, MD","credentials":["Instructor in Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Wesley Burks, MD","credentials":["Executive
Dean\n","University of North Carolina School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: FARE; NIH; Wallace
Research Foundation [Allergy and immunology]. Consultant/Advisory Boards:
ActoGeniX; Adept Field Solutions; Aimmune Therapeutics; Dynavax Technologies Corp;
FARE; Genentech; GLG Research; Insys Therapeutics; LEK Consulting; Murdoch
Children’s Research Institute; PPD Development; Regeneron Pharmaceuticals; Sanofi
US Services; SRA International; UKKO; Valeant Pharmaceuticals North America
[Allergy and immunology (Oral Immunotherapy for food, Anti-IgE, Sublingual
immunotherapy)]. Equity Ownership/Stock Options: Allertein."},{"name":"Robert Bush,
MD","credentials":["Professor Emeritus of Medicine\n","University of Wisconsin,
Madison"],"disclosure":"Other Financial Interest: Associate Editor for the Journal
of Allergy and Clinical Immunology; Section Editor for Current Allergy and Asthma
Reports; Section Editor for Current Opinions in Allergy and Immunology."},
{"name":"Angela M Caliendo, MD, PhD","credentials":["Executive Vice Chair of
Medicine\n","Brown University"],"disclosure":"Grant/Research/Clinical Trial
Support: Hologic [HIV viral load; HSV; respiratory viruses]; T2 Biosystems
[Aspergillus diagnosis]. Consultant/Advisory Boards: Roche Molecular [CMV]; Quidel
[Molecular diagnostics for infectious diseases]; Cepheid [CMV]; IDbyDNA [Genomic
testing for infectious diseases]; DNAe [Molecular diagnostics for infectious
diseases]."},{"name":"Matthew E Call, PhD","credentials":["Head of Laboratory,
Structural Biology Division\n","The Walter and Eliza Hall Institute of Medical
Research\n","Department of Medical Biology\n","The University of
Melbourne"],"disclosure":""},{"name":"Ronna L Campbell, MD, PhD","credentials":
["Associate Professor of Emergency Medicine\n","Mayo
Clinic"],"disclosure":"Consultant/Advisory Boards: INSYS Therapeutics
[Anaphylaxis]."},{"name":"Fabio Candotti, MD","credentials":["Associate
Professor\n","University Hospital of Lausanne (CHUV)"],"disclosure":""},
{"name":"Tara F Carr, MD, FAAAAI","credentials":["Assistant Professor, Medicine and
Otolaryngology\n","Department of Medicine, University of
Arizona"],"disclosure":"Speaker's Bureau: AstraZeneca [Asthma (Benralizumab)].
Consultant/Advisory Boards: AstraZeneca [Asthma (Benralizumab, budesonide-
formoterol)]; Aimmune Therapeutics Inc [Food allergy (AR101)]."},{"name":"André
Cartier, MD","credentials":["Clinical Professor of Medicine\n","University of
Montreal Medical School, Canada"],"disclosure":""},{"name":"Thomas B Casale,
MD","credentials":["Executive Vice President, American Academy of Allergy Asthma
and Immunology\n","Professor of Medicine\n","University of South
Florida"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Novartis
[Urticaria and asthma (Omalizumab)]. Consultant/Advisory Boards: Genentech;
Novartis [Urticaria and asthma (Omalizumab)]."},{"name":"Nathalie Casau-Schulhof,
MD","credentials":["Attending Physician in Infectious Diseases\n","St. Francis
Medical Center, Long Island, NY"],"disclosure":""},{"name":"Mariana C Castells, MD,
PhD","credentials":["Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Michelle S Cespedes, MD, MS","credentials":
["Associate Professor\n","Division of Infectious Disease\n","Icahn School of
Medicine at Mount Sinai"],"disclosure":"Consultant/Advisory Boards: Gilead Sciences
[HIV]."},{"name":"Nelson J Chao, MD","credentials":["Section Editor — Bone Marrow
Transplantation\n","Professor of Medicine\n","Duke University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz [GVHD
(defibrotide)]; NIH [hematopoiesis]."},{"name":"W Winn Chatham, MD","credentials":
["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":""},
{"name":"Talal Chatila, MD","credentials":["Denise and David Bunning Professor of
Pediatrics\n","Harvard Medical School\n","The Boston
Children's Hospital"],"disclosure":""},{"name":"Melvin D Cheitlin,
MD","credentials":["Emeritus Professor of Medicine\n","University of California,
San Francisco"],"disclosure":""},{"name":"Chia-Yu Chu, MD, PhD","credentials":
["Associate Professor - Department of Dermatology\n","National Taiwan University
Hospital"],"disclosure":""},{"name":"Marco Cicardi, MD","credentials":["Professor
of Medicine\n","Università degli Studi di Milano,
Italy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; CSL Behring;
Pharming; BioCryst [Hereditary angioedema (Icatibant, plasma-derived C1INH,
recombinant human C1INH, lanadelumab)]. Speaker's Bureau: Shire; CSL Behring;
Pharming [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human
C1INH)]. Consultant/Advisory Boards: Shire; CSL Behring; BioCryst; Pharvaris;
KalVista [Hereditary angioedema (Lanadelumab, subcutaneous C1INH, avoralstat, oral
anti-bradykinin, oral anti-kallikrein)]."},{"name":"Thomas D Coates,
MD","credentials":["Professor of Pediatrics and Pathology\n","University of
Southern California School of Medicine"],"disclosure":"Consultant/Advisory Boards:
Apopharma [Iron overload]; Celgene [Thalassemia]."},{"name":"Sachiko T Cochran,
MD","credentials":["Professor Emeritus\n","UCLA School of
Medicine"],"disclosure":""},{"name":"Myron S Cohen, MD","credentials":["Professor
of Medicine, Microbiology, Immunology and Public Health\n","University of North
Carolina at Chapel Hill"],"disclosure":"Consultant/Advisory Boards: Merck
[Implantable prep agents]; Gilead [HIV therapeutics for prevention and
treatment]."},{"name":"John R Cohn, MD","credentials":["Professor of Medicine and
Pediatrics\n","Thomas Jefferson University"],"disclosure":""},{"name":"Scott P
Commins, MD, PhD","credentials":["Associate Professor of Medicine\n","University of
North Carolina School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: NIH (NIAID) [Food allergy]. Speaker's Bureau: Genentech [Asthma,
urticarial (Omalizumab)]. Consultant/Advisory Boards: Aimmune [CODIT (Oral
immunotherapy)]."},{"name":"Timothy P Cooley, MD","credentials":["Associate
Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},
{"name":"Morton J Cowan, MD","credentials":["Professor Emeritus of
Pediatrics\n","University of California, San
Francisco"],"disclosure":"Consultant/Advisory Boards: Bluebird Bio [Thalassemia,
sickle cell anemia, adrenoleukodystrophy (Gene therapy)]; Exogen Bio [Radiation
therapy (Test for determining susceptibility to radiation therapy)]; Homology
Medicines [Sickle cell disease (Gene therapy)]."},{"name":"Gary M Cox,
MD","credentials":["Professor of Medicine\n","Duke University Medical
Center"],"disclosure":""},{"name":"Peter S Creticos, MD","credentials":["Section
Editor — Immunotherapy\n","Associate Professor of Medicine\n","Johns Hopkins
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Stallergenes-Greer [Immunotherapy (SLIT)]; Circassia [Immunotherapy
(Peptides)]. Consultant/Advisory Boards: Circassia; Greer; ITI [Immunotherapy
(SCIT; SLIT)]; Allakos [Cytokine antagonists]; ASIT [AIT]."},{"name":"Charlotte
Cunningham-Rundles, MD, PhD","credentials":["David S Gottesman Professor of
Immunology\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Judith S
Currier, MD","credentials":["Professor of Medicine\n","University of California,
Los Angeles"],"disclosure":"Grant/Research/Clinical Trial Support:
Theratechnologies [HIV Lipodystrophy (Egrifta)]."},{"name":"Donald Cutlip,
MD","credentials":["Section Editor — Interventional Cardiology\n","Professor of
Medicine\n","Harvard Medical School\n","Beth Israel Deaconess Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Boston Scientific
[Transcatheter aortic valve; coronary artery stent]; CeloNova [coronary artery
stent]."},{"name":"Susan Cu-Uvin, MD","credentials":["Professor of Obstetrics,
Gynecology, and Medicine\n","Brown University"],"disclosure":""},{"name":"Johanna
Daily, MD, MSc","credentials":["Section Editor — Malaria\n","Associate Professor,
Department of Medicine, Division of Infectious Diseases\n","Albert Einstein College
of Medicine"],"disclosure":""},{"name":"Reza Dana, MD, MPH, MSc","credentials":
["Claes Dohlman Professor of Ophthalmology\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Ocular
surface inflammation]; Dompe [Neurotrophic keratopathy]. Consultant/Advisory
Boards: Shire [Dry eyes]. Equity Ownership/Stock: Vision Medicines."},
{"name":"Demetre C Daskalakis, MD, MPH","credentials":["Associate
Professor\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},
{"name":"Mark DP Davis, MD","credentials":["Professor of Dermatology\n","Mayo
Clinic College of Medicine"],"disclosure":""},{"name":"Fatma Dedeoglu,
MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":""},{"name":"John F Deeken, MD","credentials":["Associate
Professor\n","Virginia Commonwealth University\n","Associate Director for Medical
Oncology and Clinical Research\n","Inova Comprehensive Cancer and Research
Institute"],"disclosure":""},{"name":"Jeffrey G Demain, MD, FAAAAI","credentials":
["Clinical Professor of Pediatrics\n","University of Washington"],"disclosure":""},
{"name":"Richard D deShazo, MD","credentials":["Billy S Guyton Distinguished
Professor\n","Professor of Medicine and Pediatrics\n","University of Mississippi
Medical Center"],"disclosure":""},{"name":"Rajiv Dhand, MD, FCCP, FACP,
FAARC","credentials":["Professor and Chairman, Department of
Medicine\n","University of Tennessee Graduate School of
Medicine"],"disclosure":"Speaker's Bureau: CIPLA [Inhaled antibiotics].
Consultant/Advisory Boards: Mylan [COPD (formoterol fumarate)]; Astra-Zeneca [COPD
(Glycopyrrolate and formoterol fumarate)]; Bayer [Ventilator-associated pneumonia
(Inhaled amikacin)]; Sunovion [COPD (Inhaled glycopyrrolate)]; GlaxoSmithKline
(Inhaled formoterol and glycopyrronium, inhaled amikacin, inhaled glycopyrrolate,
inhaled antibiotics, inhaled fluticasone-furoate and vilanterol)."},{"name":"John P
Dice, MD","credentials":["Allergy and Immunology\n","Private
Practice"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Sanofi;
TEVA Pharmaceuticals; AstraZeneca; GlaxoSmithKline; Perrigo; DBV Technologies.
Speaker's Bureau: TEVA Pharmaceuticals [Asthma, allergy (Beclomethasone
dipropionate, albuterol sulfate)]."},{"name":"Mitchell P Dombrowski,
MD","credentials":["Professor and Chief, Department of Ob/Gyn\n","Saint John
Hospital\n","Wayne State University School of Medicine"],"disclosure":""},
{"name":"Jayme Dowdall, MD","credentials":["Instructor, Department of Otology and
Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Scott Dryden-
Peterson, MD","credentials":["Assistant Professor in Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Lawrence DuBuske, MD","credentials":["Clinical
Professor of Medicine\n","George Washington University School of Medicine,
Washington, DC"],"disclosure":""},{"name":"Raed A Dweik, MD, FACP, FCCP, FRCP(C),
FCCM, FAHA","credentials":["Professor of Medicine\n","Cleveland Clinic Lerner
College of Medicine"],"disclosure":""},{"name":"Philippe A Eigenmann,
MD","credentials":["Geneva University Hospitals, Pediatric Allergy\n","University
of Geneva"],"disclosure":""},{"name":"Keith Elkon, MD","credentials":["Mannik-
Henderson Professor of Medicine\n","Head, Division of Rheumatology\n","University
of Washington"],"disclosure":""},{"name":"Dirk M Elston, MD","credentials":
["Professor and Chair, Department of Dermatology and Dermatologic
Surgery\n","Medical University of South Carolina"],"disclosure":""},{"name":"Robert
E Esch, PhD","credentials":["Adjunct Professor, School of Natural
Sciences\n","Lenoir-Rhyne University"],"disclosure":"Consultant/Advisory Boards:
Stallergenes-Greer Allergy [Allergenic extracts]."},{"name":"Amos Etzioni,
MD","credentials":["Professor Emeritus of Pediatrics and Immunology\n","The
Rappaport Faculty of Medicine, Technion, Haifa"],"disclosure":""},
{"name":"Christopher H Fanta, MD","credentials":["Professor of Medicine\n","Harvard
Medical School"],"disclosure":""},{"name":"Anna M Feldweg, MD","credentials":
["Director, Editorial Management — UpToDate\n","Deputy Editor — Allergy and
Immunology\n","Assistant Professor of Medicine, Part-time\n","Harvard Medical
School"],"disclosure":""},{"name":"David J Feller-Kopman, MD","credentials":
["Professor of Medicine\n","Johns Hopkins Hospital"],"disclosure":""},
{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular
Diseases \n","Professor of Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech
[Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy]
and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-
mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion
pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-
mediated diseases]. Employment: Mayo Clinic."},{"name":"Kevin R Flaherty, MD,
MS","credentials":["Section Editor — Interstitial Lung Disease\n","Associate
Professor of Medicine\n","University of Michigan Health
System"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer Ingelheim
[IPF (Nintedanib)]; Roche/Genentech [IPF (Pirfenidone)]. Consultant/Advisory
Boards: Boehringer Ingelheim [IPF (Nintedanib)]; Genetech [IPF (Pirfenidone)];
Roche [IPF (Pirfenidone)]; Veracyte [IPF]; Fibrogen [IPF]; Celgene [ILD]; Sanofi-
Genzyme [IPF]."},{"name":"Steven Flamm, MD","credentials":["Chief, Liver
Transplantation Program\n","Professor of Medicine\n","Feinberg School of
Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical
Trial Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck
(HCV). Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"David M
Fleischer, MD","credentials":["Associate Section Head, Pediatric Allergy and
Immunology\n","Associate Professor of Pediatrics\n","Children's Hospital
Colorado\n","University of Colorado Denver School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Monsanto Company
[Food allergy]; Nestle Nutrition Institute [Food allergy]; DBV Technologies [Food
allergies (Epicutaneous immunotherapy patch)]; Aimmune Therapeutics [Food allergies
(oral immunotherapy)]. Speaker's Bureau: Nestle Nutrition Institute [Food allergy].
Consultant/Advisory Boards: NIAID Coordinating Committee and Expert Panel, Update
to the Food Allergy Guidelines, Prevention of Peanut Allergy [Food allergy]; Food
Allergy & Anaphylaxis Connection Team (FAACT) [Food allergy]; FARE [Food allergy];
National Peanut Board [Food allergy]; DBV Technologies [Food allergy]; Aimmune
Therapeutics [Food allergy]; Intrommune Therapeutics [Food allergy]; Kaleo Pharma
[Food allergy]; INSYS Therapeutics [Food allergy]; BEFORE Brands [Food allergy]."},
{"name":"Thomas A Fleisher, MD","credentials":["Chief, Department of Laboratory
Medicine\n","National Institutes of Health Clinical Center"],"disclosure":""},
{"name":"Patricia M Flynn, MD","credentials":["Member, Department of Infectious
Diseases\n","St. Jude Children's Research Hospital\n","Professor of
Pediatrics\n","University of Tennessee, Memphis"],"disclosure":"Consultant/Advisory
Boards: Merck [Febrile neutropenia (Posaconazole)]."},{"name":"Mary Glenn Fowler,
MD, MPH","credentials":["Professor, Department of Pathology\n","Johns Hopkins
Medical Institutes"],"disclosure":""},{"name":"Michael M Frank, MD","credentials":
["Samuel L. Katz Professor of Pediatrics\n","Duke University Medical
Center"],"disclosure":"Consultant/Advisory Boards: BioCryst [Data and safety
monitoring board hereditary angioedema drugs]; Shire [Data and safety monitoring
board hereditary angioedema drugs]."},{"name":"Roy Freeman, MD","credentials":
["Professor of Neurology\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Pfizer [Neuropathic pain
(Pregabalin)]."},{"name":"Theodore Freeman, MD","credentials":["San Antonio Asthma
and Allergy Clinic"],"disclosure":""},{"name":"Timothy J Friel, MD","credentials":
["Associate Clinical Professor of Medicine\n","University of South Florida Morsani
College of Medicine"],"disclosure":""},{"name":"Daniel E Furst, MD","credentials":
["Section Editor — Treatment Issues in Rheumatology\n","Clinical professor,
University of Washington, Seattle\n","Clinical professor, University of Florence,
Florence, Italy\n","Professor of Rheumatology, University of California in Los
Angeles (Emeritus)\n","Director of Research, Pacific Arthritis
Associates"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [RA, IBD,
PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS,
PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Corbus [SSc, SLE (anabasum)]; NIH;
Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab,
tocilizumab)]. Consultant/Advisory Boards: AbbVie [RA, IBD, PMS, PsA (adalimumab)];
Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS, PsA (etanercept)]; BMS
[RA, SSc (abatacept)]; Cytori [lab test advisory]; Novartis; Pfizer [SSc
(sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab, tocilizumab)]."},
{"name":"Glenn T Furuta, MD","credentials":["Professor of Pediatrics\n","University
of Colorado School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Morphotek [Basic research]; Nutricia [clinical research].
Consultant/Advisory Boards: Shire [Consultant]. Patent Holder: Esophageal String
test [Eosinophilic esophagitis (Esophageal String Test)]. Equity Ownership/Stock
Options: Founder-EnterotTrack [Eosinophilic esophagitis (Esophageal String
Test)]."},{"name":"Rajesh T Gandhi, MD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Gilead [HIV (Tenofovir/emtricitabine/elvitegravir/cobi,
Tenofovir/emtricitabine, Tenfovir/emtricitabine/rilpivirine)]; Merck [HIV
(Raltegravir)]; Viiv [HIV (Abacavir/lamivudine/dolutegravir, Dolutegravir,
Abacavir/lamivudine)]. Consultant/Advisory Boards: Theratechnologies [HIV
(Ibalizumab)]."},{"name":"Christopher Gappy, MD","credentials":["Clinical
Instructor\n","University of Michigan, Department of Ophthalmology and Visual
Sciences"],"disclosure":""},{"name":"Andrew Gennery, MD","credentials":["Clinical
Reader/Consultant\n","Newcastle University"],"disclosure":""},{"name":"Lynn B
Gerald, PhD, MSPH","credentials":["Endowed Chair and Professor\n","Mel and Enid
Zuckerman College of Public Health, University of Arizona"],"disclosure":""},
{"name":"Susan L Gillespie, MD, PhD","credentials":["Associate Professor of
Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Marshall J
Glesby, MD, PhD","credentials":["Professor of Medicine, Healthcare Policy, and
Research\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical
Trial Support: Gilead Sciences [HIV (research support to my institution)]."},
{"name":"Stephen J Gluckman, MD","credentials":["Professor of
Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},
{"name":"Jerome Goddard, PhD","credentials":["Extension Professor of Medical and
Veterinary Entomology\n","Mississippi State University"],"disclosure":""},
{"name":"Adam O Goldstein, MD, MPH","credentials":["Professor\n","Department of
Family Medicine\n","University of North Carolina at Chapel Hill"],"disclosure":""},
{"name":"Beth G Goldstein, MD","credentials":["Adjunct Clinical Assistant
Professor\n","Department of Dermatology\n","University of North Carolina at Chapel
Hill"],"disclosure":""},{"name":"Nirmala Gonsalves, MD","credentials":["Associate
Professor of Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Speakers Bureau: Nutricia [Natural supplements (elemental
formula)]."},{"name":"Erika Gonzalez-Reyes, MD","credentials":["Associate Professor
of Pediatrics\n","Baylor College of Medicine"],"disclosure":"Speaker’s Bureau:
Novartis (Omalizumab therapy). Consultant/Advisory Boards\t: Genentech (Omalizumab
therapy)."},{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic
Institute at Cleveland Clinic\n","Center for Vasculitis Care and Research at
Cleveland clinic"],"disclosure":""},{"name":"Jason Gotlib, MD, MS","credentials":
["Professor of Medicine\n","Stanford University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell
leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)];
Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab
vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline
Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)].
Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint
Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Geoffrey S Gottlieb,
MD, PhD","credentials":["Professor of Medicine/Infectious Diseases\n","Adjunct
Professor of Global Health\n","University of Washington School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences
[HIV (emtricitabine, tenofovir DF, elvitegravir, cobicistat)]; PrEP (emtricitabine,
tenofovir DF)]; Alere [HIV (testing)]; Abbott Molecular Diagnostics [HIV
(testing)]; Cerus Corp [HIV (testing)]; Merck [HIV (EFdA, raltegravir)]; Janssen
Pharmaceutical [HIV (darunavir)]; Bristol-Meyers Squibb [HIV (BMS-986001)]; ViiV
Healthcare [HIV (Cabotegravir)]; Roche Molecular Systems [HIV (testing)]."},
{"name":"David F Graft, MD","credentials":["Adjunct Professor of
Pediatrics\n","University of Minnesota Medical School"],"disclosure":""},
{"name":"Leslie C Grammer, MD","credentials":["Professor of
Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":""},{"name":"Albert Greene, PhD","credentials":
["Entomologist and National IPM Coordinator\n","US General Services
Administration"],"disclosure":""},{"name":"Marion Groetch, MS, RD,
CDN","credentials":["Director of Nutrition Services\n","Jaffe Food Allergy
Institute\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Consultant/Advisory Boards: Nutricia North America and Mead
Johnson [CME lectures with fully control over content (Amino acid-based
hypoallergenic formulas)]."},{"name":"Jerome E Groopman, MD","credentials":["Dina
and Raphael Recanati Professor of Medicine\n","Harvard Medical
School"],"disclosure":""},{"name":"Eyal Grunebaum, MD","credentials":["Associate
Professor in Pediatrics\n","University of Toronto"],"disclosure":""},
{"name":"Michael Gurish, PhD","credentials":["Associate Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Arete Discoveries [Mast cell biology and multiple sclerosis (Proprietary
research)]. Other Financial Interest: Expert witness for Conway, Homer, and Chin-
Caplan [Autoimmunity (Provide expert opinions)]."},{"name":"Autumn Chandler Guyer,
MD","credentials":["Assistant Clinical Professor of Medicine\n","University of
California San Francisco"],"disclosure":""},{"name":"Ian P Hall, MD","credentials":
["Professor in Molecular Medicine\n","University Hospital, Nottingham,
UK"],"disclosure":""},{"name":"Robert Hallowell, MD","credentials":["Assistant
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel
L Hamilos, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School\n","Physician\n","Massachusetts General
Hospital"],"disclosure":"Consultant/Advisory
Boards: Sanofi [Drug development (Dupilumab for nasal polyposis)]; Regeneron [Drug
development (Dupilumab for nasal polyposis)]; Genentech [Drug development
(Omalizumab for nasal polyposis)]; AstraZeneca [Drug development (Benralizumab for
nasal polyposis)]."},{"name":"Robert G Hamilton, PhD, DABMLI,
FAAAAI","credentials":["Professor of Medicine and Pathology\n","Johns Hopkins
University School of Medicine"],"disclosure":""},{"name":"Pedram Hamrah,
MD","credentials":["New England Eye Center/Tufts Medical Center\n","Tufts
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: Allergan [Dry eye]; Tissue Tech [Neurotrophic keratopathy];
GlaxoSmithKline [Dry eye]; Coopervision [Contact lens discomfort]; Dompe
[Neuropathic pain]; Shire [Dry eye]; Bausch and Lomb [Inflammation].
Consultant/Advisory Boards: Shire [Dry eyes (Lifitegrast)]; Allergan [Dry eyes];
Jade [Neurotrophic keratopathy]; Valeant [Dry eyes (Hydroxypropyl cellulose
ophthalmic insert)]; Dompe [Neurotrophic keratopathy]; Aeri Pharmaceuticals
[Glaucoma]; Stemnion [Dry eye]; Santen [Dry eye]; Eyegate [Wound healing]; Revision
optics [Corneal inlays]; Heidelberg Engineering [Corneal imaging]."},{"name":"Susan
M Harding, MD, FCCP, AGAF","credentials":["Section Editor — Diagnostic
Testing\n","Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":""},{"name":"Kohei Hasegawa, MD, MPH","credentials":
["Assistant Professor \n","Harvard Medical School"],"disclosure":""},{"name":"David
Heiden, MD","credentials":["Department of Ophthalmology\n","California Pacific
Medical Center\n","San Francisco, CA\n","\n","Medical Director, AIDS Eye
Initiative\n","Seva Foundation\n","Berkeley, CA"],"disclosure":""},{"name":"Lucie
Heinzerling, MD, PhD, MPH","credentials":["Professor\n","University Hospital
Erlangen, Erlangen, Germany"],"disclosure":""},{"name":"Leslie Hendeles,
PharmD","credentials":["Professor Emeritus\n","University of
Florida"],"disclosure":""},{"name":"Vivian P Hernandez-Trujillo, MD","credentials":
["Clinical Associate Professor of Pediatrics\n","Herbert Wertheim School of
Medicine\n","Florida International University"],"disclosure":"Speaker's Bureau:
MEDA; Bayer [Asthma and allergy (Azelastine/fluticasone intranasal, Loratadine,
Flunisolide ICS)]; CSL (20% Immune Globulin). Consultant/Advisory Boards: Bayer
[Asthma and allergy (Azelastine/fluticasone intranasal, loratadine, flunisolide
ICS)]; Kaleo (Epinephrine Autoinjector); Shire/Baxalta [Primary Immunodeficiency
(Immune Globulin); Novartis [Urticaria]; Thermo Fisher [Food allergy]."},
{"name":"Dean Hess, RRT, PhD","credentials":["Teaching Associate\n","Harvard
Medical School"],"disclosure":"Consultant/Advisory Boards: Philips Respironics
[Aerosol therapy, mechanical ventilation (Nebulizers, ventilators, monitoring
equipment)]; Ventec Life Support [ventilators]; American Board of Internal Medicine
[physician credentialing]. Other Financial Interest: Jones and Bartlett [Aerosol
therapy, mechanical ventilation (textbooks)]; McGraw Hill royalty [Aerosol therapy,
mechanical ventilation (textbooks)]. Employment: Daedalus Enterprises [Aerosol
therapy, mechanical ventilation (Respiratory Care journal)]."},{"name":"Patricia L
Hibberd, MD, PhD","credentials":["Chair, Department of Global Health\n","Boston
University School of Public Health"],"disclosure":""},{"name":"Whitney A High,
MD","credentials":["Associate Professor of Dermatology and
Dermatopathology\n","University of Colorado School of Medicine"],"disclosure":""},
{"name":"Harry R Hill, MD","credentials":["Professor of Pediatrics, Pathology, and
Internal Medicine\n","University of Utah School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Horizon
Pharmaceutical [Interferon gamma]. Speaker's Bureau: Horizon Pharmaceutical
[Interferon gamma]. Consultant/Advisory Board: Horizon Pharmaceutical [Interferon
gamma]."},{"name":"Mary Beth Hogan, MD","credentials":["Vice Chair of Pediatric
Research\n","Professor of Pediatrics\n","University of Nevada, Las Vegas School of
Medicine"],"disclosure":""},{"name":"Steven M Holland, MD","credentials":
["Laboratory of Clinical Immunology and Microbiology\n","National Institutes of
Health, Bethesda, MD"],"disclosure":""},{"name":"Sandra J Hong, MD","credentials":
["Clinical Assistant Professor of Internal Medicine\n","Northeast Ohio Medical
University\n","Staff\n","Cleveland Clinic Foundation"],"disclosure":""},{"name":"C
Robert Horsburgh, Jr, MD, MUS","credentials":["Professor of Epidemiology,
Biostatistics and Medicine\n","Boston University School of Public
Health"],"disclosure":""},{"name":"Terzah M Horton, MD, PhD","credentials":
["Assistant Professor, Hematology/Oncology\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda
Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics
[Anti-CD30 antibodies (Brentuximab)]."},{"name":"Robert W Hostoffer, DO, FACOP,
FAAP, FACOI, FCCP","credentials":["Associate Professor\n","Case Western Reserve
University\n","Professor\n","Ohio University"],"disclosure":""},{"name":"William
Howe, MD","credentials":["Assistant Clinical Professor\n","University of Colorado
Denver School of Medicine"],"disclosure":""},{"name":"Brenna Hughes, MD,
MSc","credentials":["Associate Professor of Obstetrics and Gynecology\n","Duke
University"],"disclosure":""},{"name":"Gene G Hunder, MD","credentials":["Section
Editor — Vasculitis\n","Emeritus Consultant\n","Professor Emeritus\n","Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Peter H Hwang, MD","credentials":
["Professor\n","Chief, Division of Rhinology\n","Department of Otolaryngology -
Head & Neck Surgery\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Olympus [Sinus surgery
(Surgical equipment)]; Medtronic [Sinus surgery (Surgical equipment)]; 480
Biomedical [Drug delivery, sinusitis]; Arrinex [Rhinitis (Medical devices)]. Equity
Ownership/Stock Options: Intersect ENT [Drug delivery/sinusitis (Propel)]."},
{"name":"Emily P Hyle, MD","credentials":["Instructor\n","Harvard Medical
School"],"disclosure":""},{"name":"Michael Ieong, MD","credentials":["Assistant
Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},
{"name":"Charles G Irvin, PhD, FERS","credentials":["Professor\n","University of
Vermont Department of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: American Lung Association-Airways Clinical Research Centers [Asthma,
COPD]. Consultant/Advisory Boards: Methapharm [Bronchial challenge (Methacholine)];
Medical Graphic Corporation [Lung function (CPX equipment)]."},{"name":"Richard S
Irwin, MD","credentials":["Professor of Medicine\n","University of Massachusetts
Medical School"],"disclosure":""},{"name":"Elliot Israel, MD","credentials":
["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Aspirin-sensitive
asthma (Zafirlukast), biologic treatment for aspirin sensitivity (Benralizumab)];
Regeneron/Sanofi [Biologic treatment for aspirin sensitivity (Dupilumab)]; TEVA
[Biologic potentially useful for AERD (Reslizumab)] Merch [AERD (Montelukast)]."},
{"name":"Deborah S Jacobs, MD","credentials":["Associate Professor of
Ophthalmology, Part-Time\n","Harvard Medical School"],"disclosure":""},
{"name":"Mark A Jacobson, MD","credentials":["Clinical Health Sciences Professor of
Medicine\n","University of California San Francisco"],"disclosure":""},
{"name":"Kirsi M Jarvinen-Seppo, MD, PhD","credentials":["Associate Professor of
Pediatrics and Medicine\n","University of Rochester School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH NIAID [Breast
milk and infant immunology]; Bill and Melinda Gates Foundation [Breast milk
antibodies]. Consultant/Advisory Boards: Merck [Allergic rhinitis]; DBV
Technologies [Food allergy (Milk epicutaneous patch)]."},{"name":"Grace John-
Stewart, MD","credentials":["Professor, Departments of Medicine, Global Health, and
Epidemiology\n","University of Washington"],"disclosure":""},{"name":"Christine
Johnston, MD, MPH","credentials":["Assistant Professor of Medicine\n","University
of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Sanofi [HSV
vaccine (Phase I study)]; Vical [HSV vaccine (Phase II study)]; Genocea [HSV
vaccine (Phase II study)]. Consultant/Advisory Boards: Novavax."},{"name":"Richard
B Johnston, Jr, MD","credentials":["Emeritus Professor of Pediatrics\n","University
of Colorado School of Medicine\n","National Jewish Health"],"disclosure":""},
{"name":"Stephen Jolles, BSc Hons, MBChB Hons, MSc, PhD, FRCP,
FRCPath","credentials":["Consultant Clinical Immunologist & Honorary Senior
Lecturer\n","Immunodeficiency Centre for Wales\n","University Hospital of
Wales"],"disclosure":"Grant/Research/Clinical Trial Support: Baxalta [Immune
globulin (Immune globulin subcutaneous, human normal immune globulin)]; UCB Pharma
[Autoimmunity (Trial drug Data and Safety Monitoring Board)]; Grifols [Immune
globulin (Immune globulin intravenous)]; Biotest [Immune globulin (Intravenous
immune globulin)]; Octapharma [Immunoglobulin (Immune globulin intravenous, human
normal immunoglobulin, complement C1 esterase inhibitor)]; CSL Behring
[Immunoglobulin (Immune globulin subcutaneous, immune globulin intravenous)];
GlaxoSmithKline [Hypereosinophilic syndrome (Mepolizumab)]. Speaker's Bureau:
Baxalta [Immune globulin (Immune globulin subcutaneous, human normal immune
globulin)]; Biotest [Immune globulin (Intravenous immune globulin)]; Shire
[Hereditary angioedema (Icatibant)]; CSL Behring [Immunoglobulin (Immune globulin
subcutaneous, immune globulin intravenous)]; LFB [Immune globulin (10% intravenous
immune globulin)]. Consultant/Advisory Boards: Baxalta [Immune globulin (Immune
globulin subcutaneous, human normal immune globulin)];
UCB Pharma [Autoimmunity (Trial drug Data and Safety Monitoring Board)]; Sobi
[Autoinflammation (Anakinra)]; Grifols [Immune globulin (Immune globulin
intravenous)]; Biotest [Immune globulin (Intravenous immune globulin)]; Shire
[Hereditary angioedema (Icatibant)]; CSL Behring [Immunoglobulin (Immune globulin
subcutaneous, immune globulin intravenous )]; LFB [Immune globulin (10% intravenous
immune globulin)]."},{"name":"Jose Joseph-Vempilly, MD","credentials":["Professor
of Medicine\n","UCSF, Fresno"],"disclosure":""},{"name":"Sujani Kakumanu,
MD","credentials":["Clinical Assistant Professor, Division of Allergy, Pulmonary,
and Critical Care Medicine\n","University of Wisconsin Medical School and Public
Health \n","Middleton Memorial Veterans Hospital"],"disclosure":""},
{"name":"Lawrence D Kaplan, MD","credentials":["Clinical Professor of
Medicine\n","University of California, San Francisco"],"disclosure":""},
{"name":"Stephen Kells, PhD","credentials":["Associate Professor of
Entomology\n","University of Minnesota"],"disclosure":""},{"name":"John M Kelso,
MD","credentials":["Section Editor – Anaphylaxis\n","Division of Allergy, Asthma,
and Immunology\n","Scripps Clinic, San Diego, CA"],"disclosure":""},
{"name":"Stephen F Kemp, MD","credentials":["Professor of Medicine and
Pediatrics\n","University of Mississippi Medical Center"],"disclosure":""},
{"name":"David A Khan, MD","credentials":["Professor of Medicine and
Pediatrics\n","UT Southwestern Medical Center"],"disclosure":"Speaker's Bureau:
Genentech [Urticaria (Omalizumab)]. Consultant/Advisory Boards: Aimmune [Food
allergy]."},{"name":"Arthur Y Kim, MD, FIDSA","credentials":["Associate Professor
of Medicine \n","Harvard Medical School"],"disclosure":""},{"name":"Susan Kim, MD,
MMSc","credentials":["Associate Professor of Pediatrics\n","University of
California, San Francisco"],"disclosure":""},{"name":"Talmadge E King, Jr,
MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care
Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of
Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San
Francisco"],"disclosure":""},{"name":"Steven Kleinman, MD","credentials":["Section
Editor — Transfusion Medicine\n","Clinical Professor of Pathology\n","University of
British Columbia, Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp
[Pathogen reduction of blood components (Intercept Blood system)]. Equity
Ownership/Stock Options: Cerus Corp."},{"name":"Amy D Klion, MD","credentials":
["Baltimore, MD"],"disclosure":""},{"name":"Paul E Klotman, MD","credentials":
["President, CEO, and Executive Dean\n","Baylor College of
Medicine"],"disclosure":"Consultant/Advisory Boards: 98point6 [Clinical decision-
making support]. Consultant/Advisory Boards (spouse/partner): 98point6 [Clinical
decision-making support]. Equity Ownership/Stock Options: 98point6 [Clinical
decision-making support]. Equity Ownership/Stock Options (spouse/partner): 98point6
[Clinical decision-making support]."},{"name":"Alan P Knutsen, MD","credentials":
["Director, Pediatric Allergy and Immunology\n","Director, Jeffery Modell Center
for Primary Immunodeficiencies\n","Professor of Pediatrics\n","St. Louis University
Health Sciences Center"],"disclosure":""},{"name":"Igor J Koralnik,
MD","credentials":["Jean Schweppe Armour Professor of Neurology and
Medicine\n","Rush Medical College\n","Chair, Department of Neurological
Sciences\n","Section Chief, Neuroinfectious Disease\n","Rush University Medical
Center"],"disclosure":"Grant/Research Support: Biogen Idec [JC Virus)].
Consultant/Advisory Boards: Medimmune, Johnson & Johnson [JC virus]."},
{"name":"Krzysztof Kowal, MD","credentials":["Department of Allergy and Internal
Diseases\n","University Medical School, Bialystok, Poland"],"disclosure":"Speaker's
Bureau: Stallergenes; Allergopharma; HAL Allergy Group [Allergen immunotherapy
(Allergen extracts)]; Chiesi [Asthma (Beclomethasone, formoterol)]; Meda
Pharmaceuticals [Asthma (Budesonide, formoterol)]; Berlin Chemie [Allergic rhinitis
(Bilastine)]. Consultant/Advisory Boards: GlaxoSmithKline [Asthma
(Mepolizumab)]."},{"name":"Michael J Kozal, MD","credentials":["Professor of
Medicine\n","Yale University School of Medicine"],"disclosure":"Grant/Research
Support: Abbvie, Pfizer, Gilead, Hologic, Glaxo/ViiV, CytoDyn, TiaMed, Bristol-
Myers Squibb [HIV, Hepatitis C (ART therapy; HIV/HCV/HSV diagnostics)]."},
{"name":"Douglas Krakower, MD","credentials":["Division of Infectious
Diseases\n","Beth Israel Deaconess Medical Center\n","\n","Assistant Professor of
Medicine, Harvard Medical School\n","\n","Research Scientist, The Fenway
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences
[HIV prevention (Tenofovir-emtricitabine)]. Other Financial Interest: MED-IQ;
Medscape [HIV prevention]."},{"name":"Guha Krishnaswamy, MD, FACP, FCCP, FACAAI,
FAAAI, CC-D","credentials":["Professor of Medicine and Pediatrics\n","Wake Forest
University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: CSL Behring [Complications if immune deficiency (Immune globulin)]."},
{"name":"Attila Kumánovics, MD","credentials":["Assistant Professor of
Pathology\n","University of Utah School of Medicine"],"disclosure":""},
{"name":"Irving Kushner, MD","credentials":["Professor Emeritus\n","Case Western
Reserve University"],"disclosure":""},{"name":"Robert A Kyle, MD","credentials":
["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical
School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring
Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb
Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma
(Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics
Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial
Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning
a new Pfizer product and received an honorarium]."},{"name":"Denis Lafreniere,
MD","credentials":["Professor and Chief of the Division of
Otolaryngology\n","University of Connecticut Health Center"],"disclosure":""},
{"name":"Tanya M Laidlaw, MD","credentials":["Assistant Professor of
Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards:
Chiesi USA [Asthma (Zileuton)]; GlaxoSmithKline [Asthma (Mepolizumab)]; Sanofi
[Asthma (Dupilumab)]."},{"name":"Alan M Lake, MD","credentials":["Associate
Professor of Pediatrics\n","Johns Hopkins University School of
Medicine"],"disclosure":""},{"name":"Timothy R LaPine, MD","credentials":
["Professor of Pediatrics and Pathology\n","University of Utah School of
Medicine"],"disclosure":""},{"name":"Dennis K Ledford, MD","credentials":
["Professor of Internal Medicine and Pediatrics\n","University of South
Florida"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Urticaria
(Omalizumab)]; AstraZeneca [COPD (Omalizumab)]. Speaker's Bureau: AstraZeneca
[Asthma (Budesonide/formoterol)]; Boehringer-Ingelheim [Asthma (Tiotropium)];
Genentech [Asthma/urticaria (Omalizumab)]; Novartis [Asthma/urticaria
(Omalizumab)]; MEDA [Rhinitis (Fluticasone/azelastine), asthma (Flunisolide)];
Merck [Rhinitis (Ragweed/grass pollen)]; Circassia [Asthma (Measurement FeNO)].
Consultant/Advisory Boards: Boehringer-Ingelheim [Asthma (Tiotropium)]; AstraZeneca
[Asthma]. Other Financial Interest: Expert legal review [Latex allergy, metal
allergy, asthma]."},{"name":"Matthew R Leibowitz, MD","credentials":["Chief of the
Division of Infectious Diseases\n","Newton-Wellesley Hospital"],"disclosure":""},
{"name":"Michael D Leise, MD","credentials":["Assistant Professor of
Medicine\n","Mayo Clinic College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C
(Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},
{"name":"Robert F Lemanske, Jr, MD","credentials":["Professor of Pediatrics and
Medicine\n","University of Wisconsin School of Medicine and Public Health at
Madison, WI"],"disclosure":"Grant/Research/Clinical Trial Support: NHLBI [Asthma
(COAST)]; AsthmaNet [Asthma]; ORBEX [Asthma]; CTS [Clinical and translational
research]; NIH [Asthma (Inhaled corticosteroids, montelukast, tiotropium,
albuterol, azithromycin, prednisone)]; Pharmaxis [Asthma (Mannitol)]; PARK
(omalizumab). Speaker's Bureau: Latin American Congress [Asthma]; Allergy and
Asthma Foundation of Alaska [Asthma]; Louisiana State University [Asthma]. Other
Financial Interest: Elsevier [royalties]."},{"name":"Catherine Lemière,
MD","credentials":["Professor of Medicine\n","University of Montreal Medical
School"],"disclosure":""},{"name":"Alyssa R Letourneau, MD","credentials":
["Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},
{"name":"Jerrold H Levy, MD, FAHA, FCCM","credentials":["Professor of
Anesthesiology\n","Associate Professor of Surgery\n","Co-Director, Cardiothoracic
ICU\n","Duke University Hospital"],"disclosure":""},{"name":"Ofer Levy, MD,
PhD","credentials":["Associate Professor\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Crucell (Johnson &
Johnson) [Vaccines (Meningococcal and pertussis vaccines)]; Shire [Antimicrobial
proteins]. Patent Holder: Use of antimicrobial protein rBPI31 for radiation
mitigation."},{"name":"Howard Libman, MD, FACP","credentials":["Professor of
Medicine, Emeritus\n","Harvard Medical School"],"disclosure":""},{"name":"Rodger A
Liddle, MD","credentials":["Professor of Medicine\n","Duke University Medical
School"],"disclosure":""},{"name":"Phillip L Lieberman, MD","credentials":
["Clinical Professor of Medicine and Pediatrics\n","University of Tennessee College
of Medicine"],"disclosure":"Speaker's Bureau: MYLAN [Rhinitis
(Azelastine/fluticasone nasal spray)]; TEVA [Rhinitis
(Beclomethasone)]."},{"name":"Peter A Lio, MD","credentials":["Clinical Assistant
Professor of Dermatology and Pediatrics\n","Northwestern University Feinberg School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AOBiome [Atopic
dermatitis (Topical probiotic spray)]. Speaker's Bureau: Regeneron Pharmaceuticals
[Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)].
Consultant/Advisory Boards: Sanofi [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic
dermatitis (Crisaborole)]; Realm Therapeutics [Atopic dermatitis (Future
medication)]."},{"name":"M Kathryn Liszewski, PhD","credentials":["Assistant
Professor of Medicine\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Augusto A Litonjua, MD","credentials":
["Professor of Medicine and Pediatrics\n","Golisano Children's Hospital of
University of Rochester Medical Center"],"disclosure":"Consultant/Advisory Boards:
AstraZeneca, Inc [AIRS Forum Committee]."},{"name":"Mark Liu, MD","credentials":
["Associate Professor of Medicine\n","Johns Hopkins University School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline
[Asthma and COPD (Mepolizumab); Medimmune [Asthma and COPD (Tezepelumab)];
Boehringer Ingelheim [Asthma and COPD]; Amgen [Asthma and COPD (Brodalumab)];
Sanofi Aventis [Asthma and COPD (Dupilumab)]."},{"name":"Aidan Long,
MD","credentials":["Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Boards: Genentech [Asthma]; Novartis
[Asthma]; Astra-Zeneca [Asthma]."},{"name":"Fred A Lopez, MD","credentials":
["Richard Vial Professor and Vice Chair\n","Louisiana State University School of
Medicine"],"disclosure":""},{"name":"Douglas R Lotz, MD","credentials":["Clinical
Instructor in Pediatrics (Gratis)\n","University of Louisville School of
Medicine"],"disclosure":"Speaker's Bureau: Shire [Hereditary angioedema]."},
{"name":"Gregory M Lucas, MD, PhD","credentials":["Professor of Medicine\n","Johns
Hopkins University"],"disclosure":""},{"name":"J Mark Madison, MD","credentials":
["Professor of Medicine and Microbiology and Physiological Systems\n","University
of Massachusetts Medical School"],"disclosure":""},{"name":"John P Manis,
MD","credentials":["Assistant Professor of Pathology\n","Harvard Medical
School\n","Joint Program in Transfusion Medicine, Dep"],"disclosure":""},
{"name":"Norman M Mann, MD","credentials":["Assistant Clinical Professor,
Department of Medicine\n","University of Connecticut School of
Medicine"],"disclosure":""},{"name":"Richard J Martin, MD","credentials":
["Professor of Medicine\n","University of Colorado Denver, School of
Medicine"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Asthma, COPD,
biologics (IL4, 5, and 13]."},{"name":"Ursula A Matulonis, MD","credentials":
["Associate Professor of Medicine\n","Harvard Medical School \n","Director/Program
Leader\n","Medical Gynecologic Oncology\n","Dana-Farber Cancer
Institute"],"disclosure":""},{"name":"Marcus Maurer, MD","credentials":["Professor
of Dermatology and Allergy\n","Charité – Universitätsmedizin Berlin,
Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Urticaria
(Omalizumab)]; Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)];
Abbott Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; UCB
[Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]. Consultant/Advisory
Boards: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)];
Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES
[Urticaria (Bilastine)]; MSD [Urticaria (Desloratadine)]; Almirall [Urticaria
(Ebastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]; Sanofi
[Urticaria (Fexofenadine)]."},{"name":"Toby Maurer, MD","credentials":["Professor
of Dermatology\n","University of California, San Francisco, School of
Medicine"],"disclosure":""},{"name":"Kenneth H Mayer, MD","credentials":
["Infectious Disease Attending and Director of HIV Prevention Research\n","Beth
Israel Deaconess Medical Center\n","Professor of Medicine\n","Harvard Medical
School\n","Medical Research Director\n","The Fenway
Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences
[PrEP (Tenofovir-emtricitabine)]; ViiV Healthcare [PrEP (Cabotegravir)]."},
{"name":"Jennifer W McCallister, MD, FACP, FCCP","credentials":["Associate
Professor of Clinical Internal Medicine\n","The Ohio State University Wexner
Medical Center"],"disclosure":""},{"name":"Meredith C McCormack, MD,
MHS","credentials":["Assistant Professor of Medicine\n","Medical Director,
Pulmonary Function Laboratory Pulmonary and Critical Care Medicine Johns Hopkins
University"],"disclosure":""},{"name":"Douglas McDonald, MD, PhD","credentials":
["Assistant Professor of Pediatrics\n","Boston Children's Hospital\n","Harvard
Medical School"],"disclosure":""},{"name":"Malcolm McDonald, PhD, FRACP,
FRCPA","credentials":["Associate Professor\n","School of Medicine and Dentistry,
James Cook University"],"disclosure":""},{"name":"Iain B McInnes, FRCP,
PhD","credentials":["Professor of Medicine\n","University of
Glasgow"],"disclosure":"Grant/Research Support: Pfizer [Inflammatory arthritis
(Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen
[Inflammatory arthritis (Ustekinumab)]; BMS [Inflammatory arthritis (Abatacept)];
Celgene. Consultant/Advisory Boards: Pfizer [Inflammatory arthritis (Etanercept,
tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory
arthritis (Ustekinumab)]; Novartis [Inflammatory arthritis (Secukinumab)]; AbbVie
[Inflammatory arthritis (Adalimumab)]; BMS [Inflammatory arthritis (Abatacept)];
MSD [Inflammatory arthritis (Golimumab)]; Lilly [Inflammatory arthritis
(Baricitinib)]."},{"name":"Dick Menzies, MD, MSc","credentials":["Professor of
Medicine and of Epidemiology & Biostatistics\n","Montreal Chest Institute, McGill
University"],"disclosure":""},{"name":"Rachel Miller, MD, FAAAAI","credentials":
["Professor of Medicine (In Pediatrics) and Environmental Health
Sciences\n","NYPH/Columbia University"],"disclosure":""},{"name":"Jeffrey E Ming,
MD, PhD","credentials":["Adjunct Assistant Professor of Pediatrics\n","The
Children's Hospital of Philadelphia and the University of Pennsylvania School of
Medicine"],"disclosure":""},{"name":"Payam Mohammadinejad, MD","credentials":
["Research Fellow\n","Tehran University of Medical Sciences"],"disclosure":""},
{"name":"Anthony Montanaro, MD, FAAAAI","credentials":["Professor of
Medicine\n","Oregon Health and Science University"],"disclosure":""},
{"name":"Rachel A Nardin, MD","credentials":["Assistant Professor of
Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Robert S Negrin,
MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of
Medicine\n","Stanford University School of
Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz
Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular
therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock
Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals
[Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest:
American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},
{"name":"Harold Nelson, MD","credentials":["Professor of Medicine\n","National
Jewish Health\n","University of Colorado Denver School of
Medicine"],"disclosure":""},{"name":"Patrick Niaudet, MD","credentials":["Section
Editor — Pediatric Nephrology\n","Professor of Pediatrics\n","Hôpital Necker-
Enfants Malades, Paris, France"],"disclosure":""},{"name":"Tim Niehues,
MD","credentials":["Professor of Pediatrics\n","HELIOS Klinikum
Krefeld\n","Academic Hospital, RWTH Aachen University"],"disclosure":""},
{"name":"Karin Nielsen-Saines, MD, MPH","credentials":["Professor of Clinical
Pediatrics\n","Division of Infectious Diseases\n","UCLA Mattel Children's
Hospital \n","David Geffen School of Medicine at UCLA"],"disclosure":""},
{"name":"Sally A Noone, RN, MSN","credentials":["Clinical Research
Manager\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Consultant/Advisory Boards: Aimmune Therapeutics [Peanut
allergy (Quality of Life tool)]."},{"name":"Luigi D Notarangelo, MD","credentials":
["Section Editor — Immunology and Immunodeficiency\n","Bethesda,
MD"],"disclosure":""},{"name":"Anna Nowak-Węgrzyn, MD","credentials":["Associate
Professor of Pediatrics\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies;
ITN/NIAID; Astellas Pharmaceutical [Future therapies for food allergy]. Speaker's
Bureau: Thermo Fisher Scientific [Oral allergy syndrome]; International FPIES
Association [FPIES, unpaid advisor]. Consultant/Advisory Boards: Gerber Nutrition
Institute; Merck; ALK-Abello [Sublingual immunotherapy trials for pollen
allergy]."},{"name":"Paul M O'Byrne, MB, FRSC","credentials":["EJ Moran Campbell
Professor\n","McMaster University, Canada"],"disclosure":"Grant/Research/Clinical
Trial Support: AstraZeneca [Asthma (Budesonide/Formoterol)]; GlaxoSmithKline
[Asthma (Salmeterol/Fluticasone)]; Genentech [Asthma (Omalizumab)]; Novartis
[Asthma]. Consultant/Advisory Boards: AstraZeneca [Asthma (Budesonide/Formoterol)];
Boehringer [Asthma (Salmeterol/Fluticasone)]; GlaxoSmithKline [Asthma
(Omalizumab)]; Merck [Asthma (Tiotropium)]; Novartis [Asthma]."},{"name":"Hans D
Ochs, MD","credentials":["Professor of Pediatrics\n","University of
Washington"],"disclosure":""},{"name":"Puneet Opal, MD, PhD","credentials":
["Associate Professor of Neurology\n","Feinberg School of Medicine, Northwestern
University"],"disclosure":"Grant/Research/Clinical Trial Support: Biohaven
[Spinocerebellar ataxia (Trigriluzole)]."},{"name":"Jordan
S Orange, MD, PhD","credentials":["Section Editor — Immunology and
Immunodeficiency\n","Professor of Pediatrics\n","Chief of Immunology, Allergy, and
Rheumatology\n","Baylor College of Medicine\n","Texas Children's
Hospital"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics; Shire; CSL
Behring; Grifols [Primary immunodeficiency (IVIG, SCIG)]."},{"name":"Liron
Pantanowitz, MD","credentials":["Professor of Pathology\n","University of
Pittsburgh Medical Center"],"disclosure":""},{"name":"Nereida A Parada,
MD","credentials":["Associate Professor of Medicine\n","Section of Pulmonary,
Critical Care and Environmental Medicine\n","Tul"],"disclosure":""},
{"name":"Kenneth Paris, MD, MPH","credentials":["Associate Professor of
Pediatrics\n","LSU Health Sciences Center New Orleans"],"disclosure":"Speaker's
Bureau: Shire [Immunodeficiency diagnosis and treatment (Immunoglobulin)].
Consultant/Advisory Boards: Shire [Immunodeficiency diagnosis and treatment
(Immunoglobulin)]; CSL Behring [Immunodeficiency diagnosis and treatment
(Immunoglobulin)]."},{"name":"Rodolfo Pascual, MD","credentials":["Associate
Professor of Internal Medicine\n","Wake Forest University Health
Sciences"],"disclosure":""},{"name":"Mark S Pasternack, MD","credentials":
["Associate Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":"Equity Ownership: Merck."},{"name":"Zara M Patel,
MD","credentials":["Assistant Professor\n","Division of Rhinology\n","Department of
Otolaryngology - Head and Neck Surgery\n","Stanford University School of
Medicine"],"disclosure":""},{"name":"Sarita U Patil, MD","credentials":
["Instructor, Allergy and Immunology\n","Massachusetts General Hospital\n","Harvard
Medical School"],"disclosure":""},{"name":"David Peden, MD","credentials":["Harry
S. Andrews Distinguished Professor of Pediatrics\n","The University of North
Carolina at Chapel Hill"],"disclosure":""},{"name":"Stanford L Peng, MD,
PhD","credentials":["Clinical Assistant Professor\n","University of
Washington"],"disclosure":""},{"name":"Elena E Perez, MD, PhD","credentials":
["Associate\n","Allergy Associates of the Palm Beaches"],"disclosure":"Speaker's
Bureau: CSL Behring [Immunology (Intravenous immune globulin)]. Consultant/Advisory
Boards: CSL Behring [Immunology (Intravenous immune globulin)]; Shire [Immunology
(Intravenous immune globulin)]; Grifols [Immunology (Intravenous immune
globulin)]."},{"name":"John R Perfect, MD","credentials":["Professor of
Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical
Trial Support: Merck [Antifungal agents (Posaconazole, isavconazole, AmBisome)];
Astellas [Antifungal agents (Posaconazole, isavuconazole, AmBisome)]; Pfizer
[Antifungal agents (Voriconazole, fluconazole)]. Consultant/Advisory Boards: Merck
[Antifungal agents (Posaconazole, isavuconazole, AmBisome)]; Astellas [Antifungal
agents (Posaconazole, isavuconazole, AmBisome)]."},{"name":"Holly Perry,
MD","credentials":["Assistant Professor of Pediatrics\n","Tufts University School
of Medicine"],"disclosure":""},{"name":"Stephen Peters, MD, PhD, FACP, FCCP,
FAAAAI, FCPP","credentials":["Professor of Medicine and Pediatrics\n","Wake Forest
University Health Sciences"],"disclosure":"Grant/Research/Clinical Trial Support:
NHLBI [AsthmaNet, SARP, SPIROMICS]; American Lung Association [Asthma clinical
research centers]; NIAID [Asthma and Allergic Disease Data Safety Monitoring
Board]; \r\nConsultant/Advisory Boards: Astra-Zeneca [Asthma and COPD]; Genentech
[Asthma and COPD, DSMB]; Medimmune [Asthma and COPD]; Novartis [Asthma and COPD];
Regeneron Sanofi-Aventis [Asthma]; Novartis [Asthma, DSMB]; Pfizer [Asthma];
Quintiles [Asthma]; TEVA [Asthma]."},{"name":"Marc Peters-Golden,
MD","credentials":["Professor of Internal Medicine\n","University of Michigan
Health System"],"disclosure":""},{"name":"Werner J Pichler, MD","credentials":
["Professor of Clinical Immunology (Emeritus)\n","University of Bern,
Switzerland"],"disclosure":"Grant/Research/Clinical Trial Support: Menarini Group
[Possible immune reactions to febuxostat]; Teleflex [Possible allergic reactions to
disinfectants]; GlaxoSmithKline (ViiV) [Possible allergic reactions to a beta-
lactam-containing metabolite]. Consultant/Advisory Boards: Teleflex [Possible
allergic reactions to disinfectants]; Roche [Human T cell biology]; Novartis
[Immune-related side effects to checkpoint inhibitors; mechanistic considerations];
Biomarin [Allergic reactions to ERT]. Equity Ownership/Stock Options: ADR-AC GmbH
(company devoted to diagnosis and research in the field of drug hypersensitivity) -
No relevant conflict on topic."},{"name":"Andrew A Pieper, MD, PhD","credentials":
["Investigator, The Harrington Discovery Institute \n","\n","Professor of
Psychiatry \n","Case Western Reserve University"],"disclosure":""},{"name":"Thomas
A E Platts-Mills, MD, PhD","credentials":["Professor and Division
Chief\n","University of Virginia Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Phadia/Thermo-Fisher
[IgE treatment (IgE assays)]."},{"name":"Todd M Pollack, MD","credentials":
["Assistant Professor in Medicine, Part-time\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Roche Molecular
Diagnostics [Initial evaluation of HIV-infected adult (HIV viral load testing)]."},
{"name":"Jay M Portnoy, MD","credentials":["Division of Allergy, Asthma and
Immunology\n","Children's Mercy Hospitals and Clinics"],"disclosure":"Speaker's
Bureau: Thermo Fisher Scientific [IgE testing]; Boehringer Ingelheim [Asthma]."},
{"name":"Manuel Praga, MD, PhD","credentials":["Professor of
Medicine\n","Complutense University, Madrid"],"disclosure":"Speaker's Bureau:
Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease
(Tolvaptan)]; Fresenius [Hemodialysis]. Consultant/Advisory Boards: Alexion
[Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease
(Tolvaptan)]; Fresenius [Hemodialysis]."},{"name":"Susan Prescott, MBBS, FRACP,
PhD","credentials":["Winthrop Professor and Pediatric Allergist and
Immunologist\n","University of Western
Australia"],"disclosure":"Grant/Research/Clinical Trial Support: Danone Nutricia
[Allergy, early life nutrition, disease prevention (Prebiotic GosFos)]. Speaker's
Bureau: Nestle Nutrition [Allergy prevention and early life nutrition
(Probiotics)]; Danone Nutricia [Allergy prevention and early life nutrition
(Prebiotic GosFos)]. Consultant/Advisory Boards: Nestle Nutrition [Allergy
prevention and early life nutrition (Probiotics)]; Danone Nutricia [Allergy
prevention and early life nutrition (Prebiotics/Probiotics)]; Bayer [Immune health
and disease prevention (Probiotics)]; Swisse Advisory Board [Vitamins and health
food supplements (Prebiotics/probiotics)]. Consultant/Advisory Boards
(spouse/partner): Genuine Health [Prebiotics, probiotics (Fermented foods)]."},
{"name":"Richard W Price, MD","credentials":["Professor Emeritus
(Active)\n","Neurology UCSF\n","San Francisco General
Hospital"],"disclosure":"Consultant/Advisory Boards: Merck [Single consultant
meeting on CNS in HIV (raltegravir)].Other Fiancial Interests: Gilead Sciences, Inc
[Honorarium and travel expenses as speaker at a meeting (Tenofovir Alafenanamide
and Fumerate, Rilpivarine, Emtriva, Elvitegravir and various combinations of these
in single pill doses.)], Merck & Co. [Honorarium and travel expenses as speaker at
a meeting (raltegravir)]."},{"name":"Jennifer M Puck, MD","credentials":["Section
Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","University
of California, San Francisco"],"disclosure":"Consultant/Advisory Boards (spouse):
Pfizer [Rare diseases]. Employment (spouse): Invitae [Gene sequencing]. Equity
Ownership/Stock Options (spouse): Invitae [Gene sequencing]."},{"name":"Thomas C
Quinn, MD","credentials":["Professor of Medicine\n","Johns Hopkins Medical
Institute"],"disclosure":""},{"name":"Benjamin A Raby, MD, MPH","credentials":
["Section Editor — Genetics\n","Associate Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Equity Ownership/Stock Options: CureSpark, Inc [General
science]. Employment (spouse): Parexel [Hematology (CRO)] - No relevant conflict on
topic."},{"name":"Rima Rachid, MD","credentials":["Assistant Professor of
Pediatrics\n","Harvard Medical School\n","Boston Children's
Hospital"],"disclosure":""},{"name":"Priya Rajendran, MD","credentials":["Clinical
Instructor\n","University of California, San Francisco"],"disclosure":""},
{"name":"Nima Rezaei, MD, PhD","credentials":["Professor of Clinical
Immunology\n","Tehran University of Medical Sciences, Tehran,
Iran"],"disclosure":""},{"name":"Nicholas L Rider, DO","credentials":["Associate
Professor of Pediatrics, Allergy and Immunology\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jeffrey Modell
Foundation [Primary immunodeficiencies]."},{"name":"William R Robinson,
MD","credentials":["Professor of Gynecologic Oncology\n","Tulane Medical
School"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor
of Nephrology and Clinical Pathology\n","University of Turin Medical
School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher
Disease)]."},{"name":"Robin Rockhold, PhD","credentials":["Professor of
Pharmacology and Toxicology\n","Associate Professor (Research) of Emergency
Medicine\n","University of Mississippi Medical Center"],"disclosure":""},
{"name":"Jürgen Kurt Rockstroh, MD","credentials":["Professor of
Medicine\n","Department of Medicine I, University of Bonn,
Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie (Hepatitis
[Glecaprevir/Pibrentasvir]); Gilead (Hepatitis [Sofosbuvir-ledipasvir]); Merck
(Hepatitis [Grazoprevir-elbasvir]). Consultant/Advisory Boards: Abbvie (HIV
[Lopinavir/r], hepatitis [Ombitasvir-paritaprevir-ritonavir,
dasabuvir, glecaprevir/pibrentasvir]); Gilead (HIV [elvitegravir/c], Hepatitis
[Sofosbuvir-ledipasvir, sofosbuvir-velpatasvir]); Janssen (Hepatitis [Simeprevir]);
Merck (HIV [Raltegravir], Hepatitis [Grazoprevir-elbasvir]); ViiV (HIV
[Dolutegravir])."},{"name":"Diana Rodriguez-Thompson, MD, MPH","credentials":
["Clinical Instructor in Obstetrics, Gynecology, and Reproductive
Biology\n","Harvard Medical School"],"disclosure":""},{"name":"Chaim M Roifman, MD,
FRCPC, FCACB","credentials":["Professor of Pediatrics and Immunology\n","University
of Toronto, Canada"],"disclosure":""},{"name":"Antonino Romano, MD","credentials":
["Professor of Medicine\n","Catholic University of the Sacred Heart\n","Presidio
Columbus, Rome, Italy"],"disclosure":"Consultant/Advisory Boards: Diater SA
[Reagents for diagnosis of penicillin allergy (DAP)]."},{"name":"Noel R Rose, MD,
PhD","credentials":["Professor of Pathology\n","Johns Hopkins University School of
Medicine"],"disclosure":""},{"name":"Harold N Rosen, MD","credentials":["Associate
Professor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Sergio
D Rosenzweig, MD","credentials":["Department of Laboratory
Medicine"],"disclosure":""},{"name":"Marc E Rothenberg, MD, PhD","credentials":
["Professor of Pediatrics\n","Cincinnati Children's Hospital Medical
Center\n","University of Cincinnati College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH; End-Allergies
Together; PCORI; CURED Foundation; Adare Pharmaceuticals [Eosinophilic esophagitis
(Fluticasone)]. Consultant/Advisory Boards: Immune Pharmaceuticals [Eosinophilic
disorders (Bertilimumab)]; PulmOne [Asthma (Laptop PFT equipment)]; Spoon Guru
[Food Allergy (Smart phone diet application)]; Celgene [Eosinophilic esophagitis
(Anti-IL-13)]; Shire [Eosinophilic esophagitis (Budesonide)]; AstraZeneca
[Eosinophilic disorders (Benralizumab)]; GlaxoSmithKline [Eosinophilic disorders
(Mepolizumab)]; Adare Pharmaceutical [Eosinophilic esophagitis (Fluticasone)].
Patent Holder: Inventor of patents submitted and owned by CCHMC. Equity
Ownership/Stock Options: Immune Pharmaceuticals [Eosinophilic disorders
(Bertilibumab)]; NKT Therapeutics [Eosinophilic esophagitis (Anti-NKT cell
antibody)]; Spoon Guru [Food allergy (Smart phone diet application)]. Other
Financial Interest: Teva Pharmaceuticals [Royalty interest (Reslizumab)]."},
{"name":"Florence Roufosse, MD","credentials":["Erasme Hospital, Department of
Internal Medicine\n","Universite Libre de Bruxelles,
Belgium"],"disclosure":"Consultant/Advisory Boards: GlaxoSmithKline
[Hypereosinophilic syndromes (Mepolizumab)]; Knopp Biosciences [Hypereosinophilic
syndromes (Dexpramipexole)]."},{"name":"Jean-Claude Roujeau, MD","credentials":
["Section Editor — Drug Eruptions\n","Emeritus Professor of
Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil,
France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis
(Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in
development)]."},{"name":"John M Routes, MD","credentials":["Professor of
Pediatrics, Medicine, Microbiology and Molecular Genetics\n","Department of
Pediatrics \n","Children's Hospital of Wisconsin \n","Medical College of
Wisconsin"],"disclosure":""},{"name":"James L Rubenstein, MD, PhD","credentials":
["Professor of Medicine, Division of Hematology/Oncology\n","University of
California, San Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma
(Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Arye Rubinstein,
MD","credentials":["Professor of Pediatrics Microbiology and Immunology\n","Albert
Einstein College of Medicine and Montefiore Hospital Medical
Center"],"disclosure":""},{"name":"Kenneth G Saag, MD, MSc","credentials":
["Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen
[Osteoporosis]; Ironwood/AstraZeneca [Gout]; Merck [Osteoporosis]; Takeda [Gout];
Horizon [Gout]; SOBI [Gout]. Consultant/Advisory Boards: Ironwood/AstraZeneca
[Gout, rheumatoid arthritis]; Takeda [Gout]; Amgen [Osteoporosis, rheumatoid
arthritis]; Merck [Osteoporosis, rheumatoid arthritis]; Abbott [Rheumatoid
arthritis]; Bristol-Myers Squibb [Rheumatoid arthritis]; Pfizer [Rheumatoid
arthritis]; Roche-Genentech [Rheumatoid arthritis]; Bayer [Rheumatoid arthritis];
Horizon [Gout]; Radius [Osteoporosis]; SOBI [Gout]; Lilly [Osteoporosis]."},
{"name":"Sarbjit Saini, MD","credentials":["Section Editor — Urticaria and
Angioedema\n","Associate Professor of Medicine\n","Johns Hopkins University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Asthma, urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)].
Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune
[Urticaria (Omalizumab)]."},{"name":"Andrew D Samel, MD","credentials":["Affiliate
Staff Member\n","Sturdy Memorial Hospital"],"disclosure":""},{"name":"Jonathan M
Samet, MD, MS","credentials":["Dean and Professor\n","Colorado School of Public
Health"],"disclosure":""},{"name":"Charles V Sanders, MD","credentials":["Edgar
Hull Professor and Chair\n","Louisiana State University School of Medicine New
Orleans"],"disclosure":"Equity Ownership/Stock Options: Baxter International,
Inc."},{"name":"Michael P Savage, MD","credentials":["Ralph J Roberts Professor of
Cardiology\n","Thomas Jefferson University"],"disclosure":""},{"name":"Deirdre
Sawinski, MD, FAST","credentials":["Assistant Professor of Medicine\n","Assistant
Medical Director, Kidney Pancreas Transplantation\n","Renal Electrolyte and
Hypertension Division\n","Hospital of the University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HW treatment
(elbasvir-grazoprevir)]."},{"name":"Paul E Sax, MD","credentials":["Section Editor
— HIV\n","Clinical Director, Division of Infectious Diseases\n","Brigham and
Women's Hospital\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV
(tenofovir, emtricitabine, elvitegravir, cobicistat, ledipasvir, sofosbuvir)];
GlaxoSmithKline [HIV (lamivudine, abacavir, dolutegravir)]. Consultant/Advisory
Boards: AbbVie [HIV (lopinavir, ritonavir)]; Bristol-Myers Squibb [HIV (atazanavir,
efavirenz)]; Gilead Sciences [HIV (tenofovir, emtricitabine, elvitegravir,
cobicistat, ledipasvir, sofosbuvir)]; GlaxoSmithKline [HIV (lamivudine, abacavir,
dolutegravir)]; Janssen Pharmaceuticals [HIV (darunavir, etravirine, rilpivirine)];
Merck [HIV (raltegravir)]."},{"name":"David T Scadden, MD","credentials":
["Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Consultant/Advisory Board: Fate [Stem cells]; Bone
Therapeutics [Orthopedics]; FOG Pharma [cancer]; Magenta Therapeutics [stem cells].
Equity Ownership/Stock Options: Fate Therapeutics; Magenta Therapeutic; Clear Creek
Bio; Agios Pharmaceuticals."},{"name":"Morris Schambelan, MD","credentials":
["Professor Emeritus of Medicine\n","University of California San
Francisco"],"disclosure":""},{"name":"Michael Schatz, MD, MS","credentials":
["Clinical Professor, Department of Medicine\n","University of California San Diego
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support:
AstraZeneca/Medimmune [Asthma (Benralizumab)]; Merck [Cough]; GlaxoSmithKline
[Asthma, (Mepolizumab)]."},{"name":"Rodney J Schlosser, MD","credentials":
["Professor and Director of Rhinology and Sinus Surgery\n","Medical University of
South Carolina"],"disclosure":"Grant/Research/Clinical Trial Support: Entellus
Medical; Intersect ENT; AstraZeneca; Roche; Sanofi; GlaxoSmithKline [Sinus
treatments (Possible treatments for nasal polyposis)]. Speaker's Bureau: Olympus;
Arrinex; Optinose; Poly-Med [Sinus treatments (Possible treatments for nasal
polyposis)]."},{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief —
Rheumatology\n","Section Editor — Basic Science\n","Professor of
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Lawrence B
Schwartz, MD","credentials":["Charles and Evelyn Thomas Professor of
Medicine\n","Virginia Commonwealth
University"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring
[Hereditary angioedema (C1INH clinical trial)]; Dyax/Shire [Hereditary angioedema
(Anti-kallikrein mAb clinical trial)]; Merck (research grant studying
desensitization of mast cells by oral immunotherapy); Asthma & Allergy Foundation
of America/Sanofi (honorarium to participate in atopic dermatitis in America
study). Speaker's Bureau (spouse): Merck (oral immunotherapy); AstraZeneca (anti-
IL5R – asthma). Consultant/Advisory Boards: Deciphera [Advisory Board (cKit
inhibitor for mastocytosis)]; Genentech [tryptase inhibitor]. Royalties:
ThermoFisher/Phadia [tryptase assay]; Millipore, Santa Cruz, BioLegend, Hycult
BioTec [anti-mast cell and –basophil mAbs]; Cecil’s Textbook of Medicine
[Anaphylaxis chapter]."},{"name":"Markus G Seidel, MD","credentials":["Professor of
Translational Pediatric Hematology and Immunology\n","Medical University of
Graz"],"disclosure":"Consultant/Advisory Boards: Shire[Hypogammaglobulinemia
(Subcutaneous immunoglobulin, hyaluronic acid)]; Novartis [Thrombocytopenia (TPOR-
agonist)]. Other Financial Interest: Novartis [Thrombocytopenia (TPOR-agonist)];
CSL Behring [Hypogammaglobulinemia (Subcutaneous IgG, immune globulin (human))];
Octapharma [Hypogammaglobulinemia (Subcutaneous IgG, immune globulin (human))]."},
{"name":"Christine M Seroogy, MD","credentials":["Associate
Professor\n","University of Wisconsin Medical School"],"disclosure":""},
{"name":"Marc Serota, MD","credentials":["Associate Professor of Dermatology and
Allergy\n","Denver VA Medical Center and Denver
University"],"disclosure":"Consultant/Advisory Board: Novartis [Dermatology
(Secukinumab)]; Sanofi Genzyme [Dermatology (Dupilumab)]; Regeneron [Dermatology
(Dupilumab)]; Pfizer [Dermatology (Apremilast)]; Abbvie [Dermatology
(Adalimumab)]; Pfizer [Dermatology (Crisaborole)]."},{"name":"Sanjeev Sethi, MD,
PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic
College of Medicine"],"disclosure":""},{"name":"Daniel J Sexton, MD","credentials":
["Editor-in-Chief — Infectious Diseases\n","Section Editor — Bacterial
Infections\n","Professor of Medicine\n","Duke University Medical
Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease
Control and Prevention; National Institutes of Health [Healthcare epidemiology].
Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical
Technologies [Medical diagnostics]; National Football League [Infection
prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock
Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture
techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related
infections]."},{"name":"Jo Shapiro, MD","credentials":["Associate Professor of
Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},
{"name":"James H Shelhamer, MD","credentials":["Deputy Chief, Critical Care
Medicine Department, Clinical Center\n","National Institutes of
Health"],"disclosure":""},{"name":"Kenneth E Sherman, MD, PhD","credentials":
["Professor of Medicine\n","University of Cincinnati College of
Medicine"],"disclosure":"Grant/Research Support: AbbVie; BMS; Gilead; Merck;
Medimmune; Innovio [HCV, HBV]; Intercept [NASH]. Consultant/Advisory Boards: Merck;
Medimmune; Abbot Laboratories [HCV, HBV]; Shionogi [Thrombocytopenia]. Other
Financial Interest: MedPace; Watermark DSMBs [NASH, HCV]."},{"name":"Wayne G
Shreffler, MD, PhD","credentials":["Massachusetts General Hospital\n","Harvard
Medical School"],"disclosure":"Consultant/Advisory Boards: Epiva Biosciences [Food
allergy]; Food Allergy Research and Education [Food allergy]; Tunitas Therapeutics
[Food allergy]."},{"name":"Scott H Sicherer, MD, FAAAAI","credentials":["Section
Editor — Food Allergy\n","Professor of Pediatrics\n","Icahn School of Medicine at
Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: HAL Allergy
[Food allergy]; Food Allergy Research and Education [Food allergy]; NIAID [Food
allergy clinical trials]. Consultant/Advisory Boards: International Association for
FPIES [FPIES]."},{"name":"Ronald C Silvestri, MD","credentials":["Assistant
Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Ronald
A Simon, MD","credentials":["Adjunct Professor, Department of Molecular and
Experimental Medicine\n","Scripps Research Institute, La Jolla,
CA"],"disclosure":""},{"name":"Raymond G Slavin, MD, MS","credentials":["Emeritus
Professor of Internal Medicine\n","Saint Louis University School of
Medicine"],"disclosure":""},{"name":"John Kelly Smith, MD","credentials":["Fellow
and Laureate ACP\n","Emeritus Professor of Medicine\n","James H Quillen College of
Medicine\n","East Tennessee State University"],"disclosure":""},{"name":"Scott B
Snapper, MD, PhD","credentials":["Associate Professor of Medicine, Harvard Medical
School"],"disclosure":""},{"name":"Marianna Sockrider, MD, DrPH","credentials":
["Associate Professor of Pediatric Pulmonology\n","Baylor College of
Medicine"],"disclosure":""},{"name":"Roland Solensky, MD","credentials":
["Lecturer\n","Oregon State University/Oregon Health and Science University College
of Pharmacy"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca
[Asthma (Benralizumab)]; Stallergenes Greer [Allergic rhinitis (Grass pollen
allergen extract, House dust mite allergen extract)]."},{"name":"Daniel H Solomon,
MD, MPH","credentials":["Matthew H. Liang Distinguished Chair in Arthritis and
Population Health\n","Professor of Medicine\n","Harvard Medical
School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Rheumatoid
arthritis (Celecoxib)]."},{"name":"Ricardo U Sorensen, MD","credentials":
["Professor Emeritus\n","LSU Health Science Center, New Orleans\n","Honorary
Professor\n","Universidad de La Frontera, Temuco, Chile"],"disclosure":""},
{"name":"Frederick S Southwick, MD","credentials":["Professor of
Medicine\n","University of Florida"],"disclosure":""},{"name":"Jonathan M Spergel,
MD, PhD, FAAAAI","credentials":["Professor of Pediatrics\n","University of
Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial
Support: NIH; AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis
(Peanut powder)]. Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and
peanut patch)]. Equity Ownership/Stock Options: DBV Technology [Peanut allergy
(Milk and peanut patch)]."},{"name":"Timothy R Sterling, MD","credentials":
["Professor of Medicine\n","Vanderbilt University School of
Medicine"],"disclosure":""},{"name":"Richard H Sterns, MD","credentials":["Editor-
in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor
Emeritus\n","University of Rochester School of Medicine and
Dentistry"],"disclosure":""},{"name":"E Richard Stiehm, MD","credentials":["Editor-
in-Chief — Allergy and Immunology\n","Section Editor — Immunology and
Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David
Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA
Biologics [Infections of respiratory syncytial virus in organ transplants
(Respiratory syncytial virus immune globulin)]."},{"name":"Jeff Stokes, MD, FAAAAI,
FACAAI","credentials":["Professor of Pediatrics\n","Washington University in St.
Louis School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH
[Asthma (Oral bacterial extracts (ORBEX))]; NIH [Asthma (Allergen immunotherapy
(AIT))]."},{"name":"James K Stoller, MD, MS","credentials":["Section Editor —
Chronic Obstructive Pulmonary Disease\n","Jean Wall Bennett Professor of Medicine,
Samson Global Leadership Academy Endowed Chair\n","Cleveland Clinic Lerner College
of Medicine\n","Chairman, Education Institute, Cleveland
Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Alpha-1
antitrypsin detection (Pooled human alpha-1 antiprotease)]. Consultant/Advisory
Boards: CSL Behring; Grifols; Shire [Alpha-1 antitrypsin detection (Pooled human
alpha-1 antiprotease)]; Arrowhead Pharmaceuticals [Alpha-1 antitrypsin
deficiency]."},{"name":"Diane E Stover, MD","credentials":["Editor — Respiratory
Infections\n","Chief, Pulmonary Service\n","Memorial Sloan Kettering Cancer
Center"],"disclosure":""},{"name":"Scott Stringer, MD","credentials":["Professor of
Otolaryngology and Communicative Sciences\n","University of Mississippi Medical
Center"],"disclosure":""},{"name":"David L Swanson, MD","credentials":["Associate
Professor of Dermatology\n","Mayo Clinic"],"disclosure":""},{"name":"Pablo Tebas,
MD","credentials":["Professor of Medicine\n","University of
Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HIV treatment
(Raltegravir)], Glaxo [Adjudication Committee (VZV vaccine)]."},{"name":"Elizabeth
TePas, MD, MS","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor —
Allergy and Immunology\n","Deputy Editor — Pediatrics\n","Instructor in
Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Chloe L Thio,
MD","credentials":["Professor of Medicine\n","Johns Hopkins
University"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences
[Hepatitis (Tenofovir disoproxil fumarate, tenofovir alafenamide)]."},
{"name":"Chandler Thompson, DMA, MS, CCC-SLP","credentials":["Speech-Language
Pathologist/Professional Voice, Department of Otolaryngology\n","Weill Cornell
Medicine, The Sean Parker Institute for the Voice"],"disclosure":""},{"name":"Carey
C Thomson, MD, MPH","credentials":["Assistant Professor, \n","Harvard Medical
School"],"disclosure":""},{"name":"James M Tracy, DO","credentials":["Assistant
Clinical Professor of Internal Medicine\n","Creighton University School of
Medicine\n","Associate Clinical Professor of Pediatrics\n","University of Nebraska
School of Medicine"],"disclosure":""},{"name":"Glenn J Treisman, MD,
PhD","credentials":["Professor of Psychiatry and Behavioral Sciences, Professor of
Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":""},
{"name":"Gulbu Uzel, MD","credentials":["Clinical Investigator\n","National
Institute of Allergy and Infectious Diseases\n","National Institutes of
Health"],"disclosure":""},{"name":"Carlos A Vaz Fragoso, MD","credentials":
["Associate Professor in Medicine (Geriatrics)\n","Yale University School of
Medicine"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN,
FAST","credentials":["Associate Professor of Medicine\n","Tufts University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas;
Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"James
Verbsky, MD, PhD","credentials":["Associate Professor of Pediatrics and
Microbiology and Molecular Genetics\n","Medical College of
Wisconsin"],"disclosure":""},{"name":"Richard S Vetter, MS","credentials":
["Department of Entomology\n","University of California,
Riverside"],"disclosure":""},{"name":"Sebastien Viatte, MD, PhD","credentials":
["Lecturer in Genetics\n","Arthritis Research UK Centre for Genetics and
Genomics\n","The University of Manchester, UK"],"disclosure":""},{"name":"Anna
Wald, MD, MPH","credentials":["Professor of Medicine, Epidemiology, and Laboratory
Medicine\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial
Support: Genocea [Herpes simplex virus (HSV therapeutic vaccine)]; Vical [Herpes
simplex virus (HSV therapeutic vaccine)]. Consultant/Advisory Boards: AiCuris
[Herpes simplex virus (novel antiviral for HSV)]; GSK [Herpes simplex virus
(therapeutic HSV vaccine)]; Merck DSMB [Varicella zoster virus
(HSV therapeutic vaccine)]."},{"name":"Julie Wang, MD","credentials":["Associate
Professor of Pediatrics\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: Aimmune [Food allergy
(Investigational oral immunotherapy product for peanut); DBV Technologies [Food
allergy (Investigational epicutaneous immunotherapy product for peanut)].
Consultant/Advisory Boards: Aimmune [Food allergy (Investigational oral
immunotherapy product for peanut)]; JDP Therapeutics [Food allergy]; DBV
Technologies [Food allergy (Investigational epicutaneous immunotherapy product for
peanut)]. Other Financial Interest (DMC member): ALK [Allergen extracts]."},
{"name":"Marilene B Wang, MD","credentials":["Professor, Division of Head and Neck
Surgery\n","David Geffen School of Medicine at UCLA"],"disclosure":""},
{"name":"David J Weber, MD, MPH","credentials":["Professor of Medicine, Pediatrics
and Epidemiology\n","University of North Carolina Schools of Medicine and Public
Health"],"disclosure":"Grant/Research/Clinical Trial Support: CDC [Infection
control]. Speaker's Bureau: Merck [Vaccines (Varicella and hepatitis B vaccine)];
Pfizer [Vaccines]. Consultant/Advisory Boards: Merck [Vaccines (Varicella and
hepatitis B vaccine)]; Pfizer [Vaccines]; Germitec [Vaccines]; PDI [Disinfection
products]; Germitec [Disinfection device]."},{"name":"Melissa Weinberg,
MD","credentials":["Assistant Clinical Professor of Medicine\n","University of
California, San Francisco"],"disclosure":""},{"name":"Miles Weinberger,
MD","credentials":["Professor Emeritus\n","University of Iowa"],"disclosure":""},
{"name":"Steven E Weinberger, MD","credentials":["Adjunct Professor of
Medicine\n","University of Pennsylvania School of Medicine\n","Executive Vice
President and CEO Emeritus\n","American College of Physicians"],"disclosure":""},
{"name":"Scott T Weiss, MD, MS","credentials":["Professor of Medicine\n","Harvard
Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis
[Asthma (Omalizamab [Anti IgE])]."},{"name":"Peter F Weller, MD,
MACP","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor —
Tropical Medicine\n","William Bosworth Castle Professor of Medicine\n","Harvard
Medical School\n","Professor of Immunology and Infectious Diseases\n","Harvard T.
H. Chan School of Public Health"],"disclosure":"Grant/Research/Clinical Trial
Support: GlaxoSmithKline [Anti-IL5 mAb for EGPA (Mepolizumab)]."},{"name":"Mark H
Wener, MD","credentials":["Section Editor — Diagnostic Issues in
Rheumatology\n","Professor of Laboratory Medicine and
Medicine/Rheumatology\n","University of
Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer-
Ingelheim [Scleroderma (Nintedanib)]; Medical Training Software [Production of
laboratory training and competency assessment software (Autoimmune Tutor)]; BioRad
[Reference lab testing for ANA patterns (ANA substrate, autoimmune diagnostics)].
Other Financial Interest: Rheumatology (Oxford) [Associate Editor (Medical
journal)]."},{"name":"Sally Wenzel, MD","credentials":["Professor of
Medicine\n","University of Pittsburgh"],"disclosure":"Grant/Research/Clinical Trial
Support: AstraZeneca [Asthma (Benralizumab]; GSK [Asthma (Mepolizumab)]; Novartis
[Asthma (Fevipiprant)]; Sanofi Aventis [Asthma (Dupliumab)]; Boehringer-Ingelheim
[Asthma (IL-23 antibody)]. Consultant/Advisory Boards: AstraZeneca [Asthma
(Benralizumab)]; Boehringer-Ingelheim [Asthma (CRTH2 antagonists)]; Novartis
[Asthma (Fevipiprant)]; Sanofi-Regeneron [Asthma (Dupilumab); Avirigen [Anti RV
drug]; Genentech [General asthma]."},{"name":"Christina West, MD,
PhD","credentials":["Department of Clinical Sciences\n","Pediatrics Umeå
University, Sweden"],"disclosure":"Speaker's Bureau: HiPP [Probiotics];
Nutricia/Danone (Pre- and probiotics); Wyeth Nutrition (Prebiotics)."},
{"name":"William L Weston, MD","credentials":["Professor Emeritus of
Dermatology\n","University of Colorado Denver School of
Medicine"],"disclosure":""},{"name":"Julian White, AM, MB, BS, MD,
FACTM","credentials":["Professor\n","The University of
Adelaide"],"disclosure":"Consultant: Seqirus (management of envenoming/use of
antivenom). Dr. White receives travel support to attend academic meetings in his
role as clinical toxinology consultant for Seqirus Ltd, but no direct income from
Seqirus, the sole producer of antivenoms for human use in Australia."},{"name":"C
Mel Wilcox, MD","credentials":["Professor of Medicine\n","University of Alabama at
Birmingham"],"disclosure":""},{"name":"David F Williams, PhD","credentials":
["Courtesy Professor of Entomology and Nematology\n","University of Florida
(Gainesville)"],"disclosure":""},{"name":"Nevin W Wilson, MD","credentials":
["Professor and Chairman of Pediatrics\n","University of Nevada, Las Vegas School
of Medicine"],"disclosure":""},{"name":"Cameron Wolfe, MBBS (Hons)","credentials":
["Director Biopreparedness \n","Duke Preparedness & Response Center \n","Division
of Infectious Diseases \n","Duke University"],"disclosure":"Grant/Research/Clinical
Trial Support: Merck [HIV]. Consultant/Advisory Boards: Astellas [Antifungal
development (Isavuconazole)]."},{"name":"Brian R Wood, MD","credentials":
["Associate Professor of Medicine\n","University of Washington Division of Allergy
and Infectious Disease"],"disclosure":""},{"name":"Robert A Wood,
MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor —
Pediatric Allergy\n","Professor of Pediatrics\n","Johns Hopkins University School
of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV
Technologies; Aimmune; Astellas; HAL-Allergy [Food allergy]."},{"name":"Eveline Wu,
MD","credentials":["Assistant Professor of Pediatrics\n","University of North
Carolina at Chapel Hill"],"disclosure":""},{"name":"Christina M Wyatt,
MD","credentials":["Associate Professor\n","Icahn School of Medicine at Mount
Sinai"],"disclosure":""},{"name":"David L Wyles, MD","credentials":["Associate
Professor of Medicine\n","Denver Health"],"disclosure":"Grant/Research/Clinical
Trial Support: AbbVie [HCV (paritaprevir/r/ombitasvir+dasabuvir)]; BMS [HCV
(daclatasvir, asunaprevir, 325)]; Gilead [HCV (sofosbuvir, ledipasvir,
velpatasvir)]; Merck [HCV (grazoprevir, elbasvir)]; Tacere [HCV (TT-034)].
Consultant/Advisory Boards: AbbVie [HCV (paritaprevir/r/ombitasvir+dasabuvir)]; BMS
[HCV (daclatasvir, asunaprevir, 325)]; Gilead [HCV (sofosbuvir, ledipasvir,
velpatasvir)]; Merck [HCV (grazoprevir, elbasvir)]."},{"name":"Leman Yel,
MD","credentials":["Associate Professor Emeritus of Clinical
Medicine\n","University of California"],"disclosure":"Employment: Shire Plc
[Immunology] - No relevant conflict on topic. Equity Ownership/Stock Options: Shire
Plc."},{"name":"Lisa R Young, MD","credentials":["Associate Professor of Pediatrics
and Medicine\n","Vanderbilt University School of Medicine"],"disclosure":""},
{"name":"Atefeh Zeinoddini, MD","credentials":["Research Fellow at Research Center
for Immunodeficiencies\n","Tehran University of Medical
Sciences"],"disclosure":""},{"name":"Bruce Zuraw, MD","credentials":["Professor of
Medicine\n","University of California San Diego"],"disclosure":"Consultant/Advisory
Boards: Shire [Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL
Behring [Hereditary angioedema (pdC1INH-nf)]; BioCryst [Hereditary angioedema];
Novartis [Allergy]; Genentech [Allergy]. Consultant/Advisory Boards (Spouse): Shire
[Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring
[Hereditary angioedema (pdC1INH-nf)]."}]},{"name":"Peer Reviewers","contributors":
[{"name":"Seema S Aceves, MD, PhD","credentials":["Associate Professor of
Pediatrics and Medicine\n","University of California, San Diego\n","Rady Children's
Hospital, San Diiego"],"disclosure":"Grant/Research/Clinical Trial Support: Ferring
Research Institute [Eosinophilic esophagitis]. Consultant/Advisory Boards:
Regeneron Pharma [Eosinophilic esophagitis (Dupilumab)]. Patent Holder: UCSD [Oral
viscous budesonide licensed by Shire]."},{"name":"Chester Alper, MD","credentials":
["Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},
{"name":"Carlos A Bacino, MD, FACMG","credentials":["Professor of Molecular and
Human Genetics\n","Baylor College of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: BioMarin
[Achondroplasia phase-II clinical trial (Vosoritide)]. Speaker's Bureau: Alexion
Pharmaceuticals [Diagnosis and management of hypophophatasia]."},{"name":"Mark
Ballow, MD","credentials":["Professor of Pediatrics\n","All Children’s
Hospital\n","University of South Florida School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring
[Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau:
Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial
(Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency
(Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire
[Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety
Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},
{"name":"Edward M Behrens, MD","credentials":["Assistant Professor of
Pediatrics\n","University of Pennsylvania School of Medicine"],"disclosure":""},
{"name":"Jonathan A Bernstein, MD","credentials":["Professor of
Medicine\n","University of Cincinnati College of Medicine"],"disclosure":""},
{"name":"Michael S Blaiss, MD","credentials":["Clinical Professor of
Pediatrics\n","Medical College of Georgia at Augusta
University"],"disclosure":"Consultant/Advisory Boards: Stallergenes Greer [Allergen
immunotherapy]; Pfizer [Over-the-counter allergy and cold medications]; ALK
[Allergen immunotherapy]; Boston Scientific [Asthma treatment]; Bayer [Over-the-
counter
allergy treatments]; PMD Healthcare [Spirometry]."},{"name":"Bruce S Bochner,
MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor —
Adult Allergy; Asthma\n","Samuel M Feinberg Professor of Medicine \n","Northwestern
University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical
Trial Support: NIAID; NHLBI, Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma,
COPD, anaphylaxis, imaging, eosinophilic granulomatosis with polyangiitis, food
allergy, Bruton's tyrosine kinase, mastocytosis]. Consultant/Advisory Boards: GSK;
AstraZeneca; TEVA; Genentech; Allakos [Eosinophil and mast cell-related disease
(Mepolizumab, reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand;
anti-Siglec-8 antibodies [Eosinophil and mast cell-associated disease (AK002 [in
clinical trials; not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos
[Eosinophil and mast cell-associated diseases (AK002 [in clinical trials; not yet
FDA-approved])]. Other Financial Interest: Elsevier [Publication royalties (Allergy
and Immunology)]."},{"name":"David Broide, MBChB","credentials":["Professor of
Medicine\n","University of California San Diego"],"disclosure":""},{"name":"Rebecca
H Buckley, MD","credentials":["Professor of Pediatrics and Immunology\n","Duke
University School of Medicine"],"disclosure":""},{"name":"Robert Bush,
MD","credentials":["Professor Emeritus of Medicine\n","University of Wisconsin,
Madison"],"disclosure":"Other Financial Interest: Associate Editor for the Journal
of Allergy and Clinical Immunology; Section Editor for Current Allergy and Asthma
Reports; Section Editor for Current Opinions in Allergy and Immunology."},
{"name":"Ronna L Campbell, MD, PhD","credentials":["Associate Professor of
Emergency Medicine\n","Mayo Clinic"],"disclosure":"Consultant/Advisory Boards:
INSYS Therapeutics [Anaphylaxis]."},{"name":"Melody C Carter, MD","credentials":
["Staff Clinician\n","National Institutes of Health"],"disclosure":""},
{"name":"Talal Chatila, MD","credentials":["Denise and David Bunning Professor of
Pediatrics\n","Harvard Medical School\n","The Boston Children's
Hospital"],"disclosure":""},{"name":"Bradley E Chipps, MD","credentials":["Capital
Allergy & Respiratory Disease Center"],"disclosure":"Speaker's Bureau: AstraZeneca
[Asthma/COPD (Budesonide and formoterol)]; Boehringer Ingelheim [Asthma/COPD
(Tiotropium)]; Circassia [Severe asthma (NIOX, FeNO)]; Genentech [Evolving Science
of ASthma (Omalizumab)]; Novartis [Asthma (Omalizumab)]; Teva [Eosinophilic asthma
(Reslizumab)]. Consultant/Advisory Boards: AstraZeneca [Asthma/COPD (Budesonide and
formoterol)]; Boehringer Ingelheim [Asthma/COPD (Tiotropium)]; Circassia [Severe
asthma (NIOX, FeNO)]; Genentech [Evolving Science of ASthma (Omalizumab)]; Novartis
[Asthma (Omalizumab)]; Teva [Eosinophilic asthma (Reslizumab)]."},{"name":"Timothy
Craig, MD","credentials":["Professor of Medicine and Pediatrics\n","Pennsylvania
State University"],"disclosure":"Grant/Research/Clinical Trial Support: Shire;
Biocryst; CSL Behring [Hereditary angioedema (alpha-1-antitrypsin)]. Speaker's
Bureau: CSL Behring; Grifols [Hereditary angioedema and alpha-1-deficiency
(Ecallantide, C1-inhibitors, icatibant, alpha1-protein)]. Consultant/Advisory
Boards: Biocryst; CSL Behring; Shire [Hereditary angioedema (Research drug)]."},
{"name":"Jason Debley, MD, MPH","credentials":["Associate Professor, Pediatrics,
Division of Pulmonary Medicine\n","Seattle Children's Hospital, University of
Washington School of Medicine"],"disclosure":""},{"name":"Richard D deShazo,
MD","credentials":["Billy S Guyton Distinguished Professor\n","Professor of
Medicine and Pediatrics\n","University of Mississippi Medical
Center"],"disclosure":""},{"name":"Damon Eisen, MBBS, MD, FRACP","credentials":
["Professor of Medicine, Townsville\n","College of Medicine and Dentistry, James
Cook University\n","Director of Clinical Research, Infectious Diseases
Physician\n","Townsville Hospital and Health Service"],"disclosure":""},
{"name":"Alejandro Escobar-Gutiérrez, PhD","credentials":["Department for
Immunology Research\n","Institute of Epidemiological Diagnosis and
Reference\n","Health Secretariat\n","Mexico City, Mexico"],"disclosure":""},
{"name":"Henry M Feder, MD","credentials":["Professor of Pediatrics and Family
Medicine\n","University of Connecticut Health Center"],"disclosure":""},
{"name":"Theodore Freeman, MD","credentials":["San Antonio Asthma and Allergy
Clinic"],"disclosure":""},{"name":"Robert C Fuhlbrigge, MD, PhD","credentials":
["Professor of Pediatrics\n","University of Colorado School of
Medicine"],"disclosure":""},{"name":"Maria I Garcia-Lloret, MD, MS","credentials":
["Associate Professor of Pediatrics\n","David Geffen School of Medicine at
UCLA"],"disclosure":""},{"name":"Lene Heise Garvey, MD, PhD","credentials":
["Specialist in Anesthesiology, Subspecialist in Allergology\n","Copenhagen
University Hospital Gentofte, Denmark"],"disclosure":""},{"name":"Andrew Gennery,
MD","credentials":["Clinical Reader/Consultant\n","Newcastle
University"],"disclosure":""},{"name":"Paul Allen Greenberger, MD","credentials":
["Professor of Medicine\n","Northwestern University Feinberg School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Immune Tolerance
Network; NIAID; Amgen [Allergic rhinitis]. Consultant/Advisory Boards: Allergy
Therapeutics [Allergic rhinitis]."},{"name":"Bodo Grimbacher, MD","credentials":
["Centre of Chronic Immunodeficiency\n","University Medical Centre
Freiburg"],"disclosure":"Grant/Research/Clinical Trial Support:BMBF; EU; Helmholtz;
DFG; DLR; DZIF, Novartis; CSL Behring, Biotest, Bristol-Myers-Squibb, Baxalta/Shire
[Immunodeficiency research (Human immunoglobulin)]. Speaker's Bureau: CSL Behring;
Baxalta/Shire; Biotest [Immunodeficiencies (Human immunoglobulin)]."},
{"name":"Alexei A Grom, MD","credentials":["Professor of Pediatrics\n","Cincinnati
Children’s Hospital Medical Center, Division of
Rheumatology"],"disclosure":"Grant/Research/Clinical Trial Support: NovImmune
[Macrophage activation syndrome and hemophagocytic lymphohistiocytosis)]. Speaker's
Bureau: Novartis [Systemic juvenile idiopathic arthritis (Canakinumab)].
Consultant/Advisory Boards: Novartis [Macrophage activation syndrome and systemic
juvenile idiopathic arthritis (Canakinumab)]; Ab2Bio [Macrophage activation
syndrome and systemic juvenile idiopathic arthritis (IL18BP)]."},{"name":"Gary N
Gross, MD","credentials":["Clinical Professor Internal Medicine\n","University of
Texas Southwestern Medical School"],"disclosure":"Grant/Research/Clinical Trial
Support: Stallergens [Allergic rhinitis (Sublingual tablets)]. Speaker's Bureau:
ALK [Allergy rhinitis (Sublingual tablets)]."},{"name":"Sudhir Gupta, MD, PhD,
MACP","credentials":["Professor of Medicine, Pathology & Laboratory Medicine, and
Microbiology & Molecular Genetics \n","Chief, Basic and Clinical Immunology
\n","University of California, Irvine"],"disclosure":"Grant/Research/Clinical Trial
Support: Baxalta/Shire [Investigator research grant]; Octapharma; ProMetic; BPL."},
{"name":"Kathleen M Gura, PharmD, BCNSP, FASHP","credentials":["Assistant Professor
of Pediatrics\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical
Trial Support: Fresenius Kabi [Parenteral nutrition-associated liver disease
(Intravenous lipid emulsions)]; ProNova/BASF [Omega-3 fatty acids (Fish oil)];
Sancilio & Company [Omega-3 fatty acids (Fish oil)]. Consultant/Advisory Boards:
Sancilio & Company [Omegaven-3 fatty acids (Fish oil)]; B Braun
[Pharmacy/Parenteral nutrition compounding (Intravenous lipid emulsions)];
ProNova/BASF [Omega-3 fatty acids (Fish oil)]. Patent Holder: [Liver disease
associated with parenteral nutrition (Omegaven)]. Other Financial Interest:
Licensing agreement - Boston Children’s Hospital and Fresenius Kabi [Parenteral
nutrition-associated liver disease (Intravenous fish oil)]."},{"name":"Robert G
Hamilton, PhD, DABMLI, FAAAAI","credentials":["Professor of Medicine and
Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},
{"name":"Derralynn Hughes, MD","credentials":["Senior Lecturer Honorary
Consultant\n","University College London\n","Royal Free
London"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Gaucher
disease (Imiglucerase); Genzyme [Gaucher disease (Velaglucerase)].
Grant/Research/Clinical Trial Support (spouse): Shire [Gaucher disease
(Imiglucerase)]. Speaker's Bureau: Shire [Gaucher disease (Imiglucerase)]l Genzyme
[Gaucher disease (Velaglucerase)]. Speak'er's Bureau (spouse): Shire [Gaucher
disease (Imiglucerase)]. Consultant/Advisory Boards: Shire [Gaucher disease
(Imiglucerase)]; Genzyme [Gaucher disease (Velaglucerase)]; Protalix [Gaucher
disease (Taliglucerase)]; Actelion [Gaucher disease (Miglustat)].
Consultant/Advisory Boards (spouse): Shire [Gaucher disease (Imiglucerase)]."},
{"name":"Allen P Kaplan, MD","credentials":["Clinical Professor\n","Medical
University of South Carolina"],"disclosure":"Consultant/Advisory Boards: Sanofi-
Aventis [Allergic reactions]; Genentech [Angioedema]."},{"name":"Corinne Keet, MD,
PhD","credentials":["Assistant Professor of Pediatrics\n","Johns Hopkins School of
Medicine"],"disclosure":""},{"name":"John M Kelso, MD","credentials":["Section
Editor – Anaphylaxis\n","Division of Allergy, Asthma, and Immunology\n","Scripps
Clinic, San Diego, CA"],"disclosure":""},{"name":"Stephen F Kemp,
MD","credentials":["Professor of Medicine and Pediatrics\n","University of
Mississippi Medical Center"],"disclosure":""},{"name":"Carolyn M Kercsmar,
MD","credentials":["Professor of Pediatrics\n","University of Cincinnati School of
Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [Asthma
(Mepolizumab)]"},{"name":"David A Khan, MD","credentials":["Professor of Medicine
and Pediatrics\n","UT Southwestern Medical Center"],"disclosure":"Speaker's
Bureau: Genentech [Urticaria (Omalizumab)]. Consultant/Advisory Boards: Aimmune
[Food allergy]."},{"name":"Marek L Kowalski, MD, PhD","credentials":["Professor of
Medicine \n","Medical University of Lodz, Poland"],"disclosure":""},
{"name":"Richard D Kramer, PhD","credentials":["Entomologist,
President\n","Innovative Pest Management"],"disclosure":""},{"name":"Deidre R
Larrier, MD","credentials":["Assistant Professor of Pediatric
Otolaryngology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Jerrold H
Levy, MD, FAHA, FCCM","credentials":["Professor of Anesthesiology\n","Associate
Professor of Surgery\n","Co-Director, Cardiothoracic ICU\n","Duke University
Hospital"],"disclosure":""},{"name":"H Henry Li, MD, PhD, CPI","credentials":
["Director of Immunology\n","Institute for Asthma and
Allergy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; Viropharma;
Dyax; Biocryst; CSL Behring; Pharming; Salix [Hereditary angioedema (C1 esterase
inhibitor [human], C1 esterase inhibitor [recombinant], icatibant injection,
ecallantide)]. Speaker's Bureau: Shire; CSL Behring [Hereditary angioedema (C1
esterase inhibitor [human], icanibant injection, ecallantide)]. Consultant/Advisory
Boards: Shire; US Hereditary Angioedema Association; Pharming; Salix; CSL Behring
[Hereditary angioedema (C1 esterase inhibitor [human], C1 esterase inhibitor
[recombinant], icatibant injection, ecallantide]. Employment: Institute for Asthma
and Allergy [Allergy (clinic)]."},{"name":"Phillip L Lieberman, MD","credentials":
["Clinical Professor of Medicine and Pediatrics\n","University of Tennessee College
of Medicine"],"disclosure":"Speaker's Bureau: MYLAN [Rhinitis
(Azelastine/fluticasone nasal spray)]; TEVA [Rhinitis (Beclomethasone)]."},
{"name":"Nirupama Madduri, MD","credentials":["Assistant Professor of
Pediatrics\n","University of Southern California Keck School of
Medicine"],"disclosure":""},{"name":"Stephen McGeady, MD","credentials":["Professor
of Pediatrics\n","Sidney Kimmel Medical College, Thomas Jefferson
University\n","Attending Physician\n","AI DuPont Hospital for
Children"],"disclosure":""},{"name":"J Lawrence Merritt II, MD","credentials":
["Associate Professor\n","University of Washington School of Medicine, Seattle
Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme
[Gaucher disease, Pompe disease (Imiglucerase, Alglucosidase alfa)].
Consultant/Advisory Boards: Synlogic, Inc (inborn errors of metabolism)."},
{"name":"Michael D Nelson, MD, PhD","credentials":["Virginia S. Lang Professor and
Vice Chairman of Obstetrics and Gynecology\n","Washington University School of
Medicine"],"disclosure":""},{"name":"Tim Niehues, MD","credentials":["Professor of
Pediatrics\n","HELIOS Klinikum Krefeld\n","Academic Hospital, RWTH Aachen
University"],"disclosure":""},{"name":"Luigi D Notarangelo, MD","credentials":
["Section Editor — Immunology and Immunodeficiency\n","Bethesda,
MD"],"disclosure":""},{"name":"John Oppenheimer, MD","credentials":["Professor of
Medicine \n","University of Medicine and Dentistry of New Jersey-
Rutgers"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma
(Omalizumab)]; Medimmune [Asthma (Benralizumab and Tralokinumab)]; Teva [Asthma
(Reslizumab)]. Consultant/Advisory Boards: Kaleo[Anaphylaxis]; GlaxoSmithKline
[Asthma]; AZ [Asthma]; Sanofi [Asthma]; DBV [Food allergy]. Other Financial
Interest: Annals of Allergy, AllergyWatch [Associate Editor]; Medscape [Associate
Editor - Pulmonary]."},{"name":"Elena E Perez, MD, PhD","credentials":
["Associate\n","Allergy Associates of the Palm Beaches"],"disclosure":"Speaker's
Bureau: CSL Behring [Immunology (Intravenous immune globulin)]. Consultant/Advisory
Boards: CSL Behring [Immunology (Intravenous immune globulin)]; Shire [Immunology
(Intravenous immune globulin)]; Grifols [Immunology (Intravenous immune
globulin)]."},{"name":"Elizabeth J Phillips, MD, FRCPC, FRACP, FIDSA,
FAAAAI","credentials":["Professor of Medicine & Pharmacology\n","John A. Oates
Chair in Clinical Research\n","Vanderbilt University Medical Center\n","Institute
for Immunology & Infectious Diseases"],"disclosure":""},{"name":"Jay M Portnoy,
MD","credentials":["Division of Allergy, Asthma and Immunology\n","Children's Mercy
Hospitals and Clinics"],"disclosure":"Speaker's Bureau: Thermo Fisher Scientific
[IgE testing]; Boehringer Ingelheim [Asthma]."},{"name":"Lisa Prock, MD,
MPH","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical
School"],"disclosure":""},{"name":"Nima Rezaei, MD, PhD","credentials":["Professor
of Clinical Immunology\n","Tehran University of Medical Sciences, Tehran,
Iran"],"disclosure":""},{"name":"Chaim M Roifman, MD, FRCPC, FCACB","credentials":
["Professor of Pediatrics and Immunology\n","University of Toronto,
Canada"],"disclosure":""},{"name":"Lanny J Rosenwasser, MD","credentials":
["Professor of Medicine\n","University of Missouri-Kansas City School of
Medicine"],"disclosure":""},{"name":"Kelly A Rouster-Stevens, MD,
MS","credentials":["Assistant Professor of Pediatrics\n","Emory University School
of Medicine"],"disclosure":""},{"name":"Anne Rowley, MD","credentials":["Professor
of Pediatrics and of Microbiology and Immunology\n","Northwestern University
Feinberg School of Medicine"],"disclosure":""},{"name":"Lawrence B Schwartz,
MD","credentials":["Charles and Evelyn Thomas Professor of Medicine\n","Virginia
Commonwealth University"],"disclosure":"Grant/Research/Clinical Trial Support: CSL
Behring [Hereditary angioedema (C1INH clinical trial)]; Dyax/Shire [Hereditary
angioedema (Anti-kallikrein mAb clinical trial)]; Merck (research grant studying
desensitization of mast cells by oral immunotherapy); Asthma & Allergy Foundation
of America/Sanofi (honorarium to participate in atopic dermatitis in America
study). Speaker's Bureau (spouse): Merck (oral immunotherapy); AstraZeneca (anti-
IL5R – asthma). Consultant/Advisory Boards: Deciphera [Advisory Board (cKit
inhibitor for mastocytosis)]; Genentech [tryptase inhibitor]. Royalties:
ThermoFisher/Phadia [tryptase assay]; Millipore, Santa Cruz, BioLegend, Hycult
BioTec [anti-mast cell and –basophil mAbs]; Cecil’s Textbook of Medicine
[Anaphylaxis chapter]."},{"name":"Reinhard Seger, MD","credentials":["Professor
Emeritus of Pediatric Immunology/BMT\n","University Children's Hospital\n","Zürich,
Switzerland"],"disclosure":""},{"name":"Irini Sereti, MD, MHS","credentials":["ID
physician\n","Washington, DC"],"disclosure":""},{"name":"Roland Solensky,
MD","credentials":["Lecturer\n","Oregon State University/Oregon Health and Science
University College of Pharmacy"],"disclosure":"Grant/Research/Clinical Trial
Support: AstraZeneca [Asthma (Benralizumab)]; Stallergenes Greer [Allergic rhinitis
(Grass pollen allergen extract, House dust mite allergen extract)]."},{"name":"Mary
Beth F Son, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard
Medical School"],"disclosure":""},{"name":"Jonathan M Spergel, MD, PhD,
FAAAAI","credentials":["Professor of Pediatrics\n","University of Pennsylvania
School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH;
AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis (Peanut powder)].
Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and peanut patch)].
Equity Ownership/Stock Options: DBV Technology [Peanut allergy (Milk and peanut
patch)]."},{"name":"Joan M Stoler, MD","credentials":["Assistant Professor of
Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Alan Sugar,
MD","credentials":["Professor and Vice Chair, Ophthalmology and Visual
Sciences\n","WK Kellogg Eye Center\n","University of Michigan Medical
School"],"disclosure":""},{"name":"Kathleen Sullivan, MD, PhD","credentials":
["Professor of Pediatrics\n","Children's Hospital of
Philadelphia"],"disclosure":"Consultant/Advisory Board: Immune deficiency
foundation [Immune deficiency]. Other Financial Interest (Royalties): Elsevier
[Textbook]."},{"name":"Angela Sun, MD","credentials":["Assistant Professor of
Pediatrics\n","University of Washington School of Medicine\n","Seattle Children's
Hospital"],"disclosure":""},{"name":"Troy R Torgerson, MD, PhD","credentials":
["Associate Professor of Pediatrics\n","University of Washington\n","Seattle
Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter
Biosciences [Immunodeficiency diagnostics (IVIG/SCIG)]; CSL Behring
[Immunodeficiency diagnostics (IVIG/SCIG)]. Consultant/Advisory Boards: Baxalta,
CSL Behring, ADMA Biosciences [Immunodeficiency (IVIG/SCIG)]."},{"name":"James
Verbsky, MD, PhD","credentials":["Associate Professor of Pediatrics and
Microbiology and Molecular Genetics\n","Medical College of
Wisconsin"],"disclosure":""},{"name":"Michael E Weiss, MD","credentials":["Clinical
Professor of Medicine\n","University of Washington, School of
Medicine\n","Northwest Asthma & Allergy Center"],"disclosure":""},{"name":"Pamela F
Weiss, MD, MSCE","credentials":["Associate Professor\n","Departments of Pediatrics
and Epidemiology\n","Perelman School of Medicine, University of
Pennsylvania\n","Division of Rheumatology, Children's Hospital of
Philadelphia"],"disclosure":"Grant/Research Clinical Trial Support: PCORI
[Polyarticular JIA comparative effectiveness]; Arthritis Foundation [Polyarticular
JIA]. Consultant/Advisory Boards: Lilly [Arthritis (Baricitinib and
ixekizumab)]."},{"name":"Michael J Welch, MD, FAAAAI","credentials":["Clinical
Professor\n","University of California, San Diego School of
Medicine"],"disclosure":""},{"name":"Kevin L Winthrop, MD, MPH","credentials":
["Professor, School of Public Health\n","Associate Professor, Department of
Medicine\n","Divisions of Infectious Disease and Ophthalmology, \n","Oregon Health
and Sciences University"],"disclosure":"Grant/Research/Clinical Trial Support:
Bristol-Myers Squibb [vaccine]. Consultant/Advisory
Boards: Pfizer [Rheumatology (Tofacitinib, etanercept)]; UCB [Rheumatology
(Certolizumab); Amgen, Abbvie [Rheumatology (Adalimumab)]."},{"name":"Robert S
Zeiger, MD, PhD","credentials":["Clinical Professor of Pediatrics \n","University
of California, San Diego"],"disclosure":"Consultant/Advisory Boards: DBV
Technologies [Food allergy (Epicutaneous immunotherapy)]. Equity Ownership/Stock
Options: DBV Technologies [Food allergy (Epicutaneous immunotherapy)]."}]}]}